Benign neoplasm of colon, rectum, anus and anal canal

CD2_BENIGN_COLORECANI

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — D12 Cause of death: ICD-10 — D12 2 out of 7 registries used, show all original rules.	32714
4. Check minimum number of events None	32714
5. Include endpoints CD2_BENIGN_COLON CD2_BENIGN_RECTOSIGMOID_JUNC CD2_BENIGN_RECTUM_ANAL	33210
6. Filter based on genotype QC (FinnGen only)	32220

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 2
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: D10-D36
Name in latin: Neoplasma benignum intestini crassi

NAME	CD2_BENIGN_COLORECANI
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	CD2_BENIGN_COLON\|CD2_BENIGN_RECTOSIGMOID_JUNC\|CD2_BENIGN_RECTUM_ANAL
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	D12
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	D12
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Benign neoplasm of colon, rectum, anus and anal canal based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	166694	83081	82674
Only index persons	152318	77591	74727
Unadjusted period prevalence (%)
Whole population	2.34	2.38	2.31
Only index persons	2.85	2.85	2.85
Median age at first event (years)
Whole population	66.20	66.21	66.18
Only index persons	65.73	65.73	65.74

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	32220	15891	16329
Unadjusted period prevalence (%)	6.57	5.64	7.48
Median age at first event (years)	65.86	64.63	67.06

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
33209: Matched controls
288258

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

R06.0

ICD-10 Finland

Dyspnoea

1.7

319.5

9076

53476

J01DB01

ATC

cefalexin; oral

1.7

312.2

26548

201779

R07.4

ICD-10 Finland

Chest pain, unspecified

1.6

309.9

9625

57905

I84.9

ICD-10 Finland

Unspecified hemorrhoids without complication

2.7

309.7

1867

6301

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

142.4

307.7

8215

664

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.1

307.7

3890

16895

D12.1

ICD-10 Finland

Benign neoplasm: Appendix

380.9

307.7

392

D12.3

ICD-10 Finland

Benign neoplasm: Transverse colon

104.0

307.7

4311

413

P01AB01

ATC

metronidazole; oral, rectal

1.7

307.7

12858

79693

D12

ICD-10 Finland

Benign neoplasm of colon, rectum, anus and anal canal

12.3

307.7

365

260

Z12.1

ICD-10 Finland

Special screening examination for neoplasm of intestinal tract

7.1

307.7

673

839

JGA05

NOMESCO Finland

Endoscopic polypectomy in rectum

37.3

307.7

629

149

B01AB05

ATC

enoxaparin; parenteral

1.7

307.7

11229

66558

D12.8

ICD-10 Finland

Benign neoplasm: Rectum

165.5

307.7

7749

529

UJF32

NOMESCO Finland

Coloscopy

13.2

307.7

23115

42503

A06AC01

ATC

ispaghula (psylla seeds); oral

2.3

307.7

10973

50229

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

4.9

307.7

12533

31908

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.8

307.7

16979

104218

JFA52

NOMESCO Finland

Other endoscopic haemostatic procedure in colon

51.9

307.7

448

WX002

NOMESCO Finland

Sedation and analgesia

1.8

307.7

6962

36614

A02BC05

ATC

esomeprazole; systemic

1.6

307.7

13558

87230

JGA73

NOMESCO Finland

Transanal excision of lesion of rectum

123.9

307.7

311

UJG02

NOMESCO Finland

Proctoscopy

4.3

307.7

1089

2265

JFA45

NOMESCO Finland

Endoscopic contact coagulation in colon

18.4

307.7

484

231

UJF30

NOMESCO Finland

Ileoscopy through colon

6.5

307.7

7675

12732

D37.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Rectum

7.4

307.7

577

686

JN3AD

NOMESCO Finland

Abdominal CT examination

2.1

307.7

4230

19003

Z2221

NOMESCO Finland

Medical doctor

1.7

307.7

8734

50629

N02AX02

ATC

tramadol; systemic, rectal

1.6

307.7

14613

95943

D12.9

ICD-10 Finland

Benign neoplasm: Anus and anal canal

329.6

307.7

1066

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

68.0

307.7

10807

2031

JFB31

NOMESCO Finland

Laparoscopic right hemicolectomy

7.2

307.7

888

1091

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

25.4

307.7

2258

824

Z01.8

ICD-10 Finland

Other specified special examinations

1.9

307.7

8044

41882

A02BC02

ATC

pantoprazole; systemic

1.9

307.7

23632

163404

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.0

307.7

4682

22299

D12.4

ICD-10 Finland

Benign neoplasm: Descending colon

101.2

307.7

2731

255

JFA55

NOMESCO Finland

Other endoscopic procedure using diathermy or heat in colon

17.8

307.7

377

186

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

4.1

307.7

1232

2654

K63.5

ICD-10 Finland

Polyp of colon

5.2

307.7

1165

2018

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

372.6

307.7

11215

394

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.9

307.7

6828

34580

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

4.1

307.7

1006

2180

TPH04

NOMESCO Finland

Cathetrisation of vein

1.7

307.7

7575

41908

D12.7

ICD-10 Finland

Benign neoplasm: Rectosigmoid junction

128.3

307.7

1537

109

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

3.2

307.7

3676

10680

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

3.4

307.7

2659

7267

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

3.4

307.7

2928

7917

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.1

307.7

12963

67911

K64.0

ICD-10 Finland

First degree haemorrhoids

4.1

307.7

954

2042

JFA42

NOMESCO Finland

Endoscopic injection in colon

59.0

307.7

496

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

5.9

307.7

6241

10880

D37.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Colon

7.0

307.7

1008

1280

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.5

307.7

3319

12093

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.2

307.7

3890

16412

K92.1

ICD-10 Finland

Melaena

3.0

307.7

2451

7491

UJH02

NOMESCO Finland

Anoscopy

3.3

307.7

1861

5028

D12.0

ICD-10 Finland

Benign neoplasm: Caecum

122.2

307.7

4251

346

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.3

307.7

4802

19803

D12.2

ICD-10 Finland

Benign neoplasm: Ascending colon

110.1

307.7

5757

548

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.9

307.7

3497

11202

K62.1

ICD-10 Finland

Rectal polyp

8.1

307.7

677

740

JFA85

NOMESCO Finland

Endoscopic mucosal or submucosal resection in colon

156.8

307.7

251

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

3.2

307.7

14511

56851

D64.9

ICD-10 Finland

Anaemia, unspecified

2.4

307.7

4563

18227

N02BE01

ATC

paracetamol; systemic, rectal

2.2

307.7

29611

228292

WX408

NOMESCO Finland

General anesthesy, balanced

1.6

299.4

8539

50209

S18

ICPC

Laceration/cut

1.5

289.4

15045

101365

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.8

283.4

5564

29529

UJF92

NOMESCO Finland

Capsular endoscopy

4.0

283.1

865

1925

C03CA01

ATC

furosemide; systemic

1.6

282.7

10698

67113

A02BC03

ATC

lansoprazole; oral

1.6

282.2

9670

59285

WX302

NOMESCO Finland

Thoracal epidural anesthesy

2.4

282.2

2045

7536

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

4.7

280.3

697

1320

C05AA08

ATC

fluocortolone; rectal, topical

1.8

277.8

4701

23853

JN4AD

NOMESCO Finland

Body CT examination

1.9

274.6

3757

17795

J01MA02

ATC

ciprofloxacin; systemic

1.5

265.3

12935

85449

D01

ICPC

Abdominal pain/cramps general

2.0

263.1

3454

16116

H02AB06

ATC

prednisolone; systemic

1.5

263.0

15424

105791

N03AX16

ATC

[U] pregabalin

1.6

259.1

7700

45461

JN4BD

NOMESCO Finland

Extensive body CT

1.9

257.7

3777

18279

D13.1

ICD-10 Finland

Benign neoplasm: Stomach

3.4

257.4

1000

2623

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

3.0

256.5

1198

3515

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.8

254.0

1341

4214

R4110

NOMESCO Finland

Physiotherapy

1.6

251.6

8936

54947

JHA20

NOMESCO Finland

Excision of lesion of anal canal or perianal tissue

5.4

247.9

516

835

Z98.0

ICD-10 Finland

Intestinal bypass and anastomosis status

9.5

247.5

315

291

Z80.0

ICD-10 Finland

Family history of malignant neoplasm of digestive organs

7.4

245.3

381

454

AA1AD

NOMESCO Finland

CT of head and brain

1.5

244.3

9174

57044

C07AB07

ATC

bisoprolol; oral

1.5

241.3

16573

116516

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.4

238.2

1804

6770

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.0

236.0

3068

14239

WZC00

NOMESCO Finland

Treatment plan or consultation

1.5

235.6

11036

71808

8140/3-C18.7

ICD-O-3

Adenocarcinoma, NOS, of sigmoid colon

4.8

233.1

555

1013

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.7

232.9

4813

25775

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

3.9

232.2

720

1619

UKC02

NOMESCO Finland

Cystoscopy

1.7

232.0

5638

31534

R03AC02

ATC

salbutamol; inhalant

1.5

231.5

16498

116436

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

230.4

12814

86190

M79.6

ICD-10 Finland

Pain in limb

1.5

227.6

12713

85521

I10

ICD-10 Finland

Essential (primary) hypertension

1.5

227.0

20729

153106

C20.92

ICD-10 Finland

Malignant tumor of the rectum carcinoma of the adenoma

7.1

226.8

365

453

K59.09

ICD-10 Finland

Constipation, unspecified

2.1

225.3

2372

10194

ZXD10

NOMESCO Finland

Scheduled procedure

1.5

224.5

12000

79969

K55.2

ICD-10 Finland

Angiodysplasia of colon

6.8

224.3

374

483

TPH07

NOMESCO Finland

Cathetrisation of artery

1.8

224.1

3878

19714

A07EC02

ATC

mesalazine; oral, rectal

2.4

222.8

1745

6643

JFB30

NOMESCO Finland

Right hemicolectomy

4.1

215.4

635

1375

JGA85

NOMESCO Finland

Endoscopic mucosal or submucosal resection in rectum

282.5

212.6

228

C18.72

ICD-10 Finland

Malignant tumor of sigmoid carcinoma of adenoma

9.5

211.7

269

248

D16

ICPC

Rectal bleeding

3.1

204.2

886

2487

8263/2-C20.9

ICD-O-3

Adenocarcinoma in situ in tubulovillous adenoma of rectum, NOS

36.4

198.5

138

G04CA02

ATC

tamsulosin; oral

1.5

196.9

8135

51176

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.6

196.4

5560

32154

K64.9

ICD-10 Finland

Haemorrhoids, unspecified

2.7

196.2

1133

3727

A02BC01

ATC

omeprazole; systemic

1.5

196.1

8669

55284

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.5

193.7

8062

50764

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.4

193.1

13752

95850

A06AD11

ATC

lactulose; oral

1.6

192.6

4872

27397

C18.70

ICD-10 Finland

Malignant tumor of the sigmoid without histology

4.3

192.4

520

1053

J45.9

ICD-10 Finland

Asthma, unspecified

1.6

192.3

5738

33580

K29.7

ICD-10 Finland

Gastritis, unspecified

2.5

191.5

1286

4558

WX110

NOMESCO Finland

Infiltration anesthesia

1.4

189.5

21102

158766

21140

ICD-8 Finland

Benign neoplasm of other parts of digestive system, Rectum

+∞

188.5

191

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.5

187.7

8028

50771

D13.2

ICD-10 Finland

Benign neoplasm: Duodenum

6.1

187.0

345

496

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.6

186.4

5634

33045

XKD00

NOMESCO Finland

Uroflowmetry

1.6

184.5

5406

31468

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.4

183.9

10862

73019

K59.1

ICD-10 Finland

Functional diarrhoea

2.2

183.9

1773

7348

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

2.4

183.7

1355

5015

M54.5

ICD-10 Finland

Low back pain

1.4

183.3

10328

68825

R53

ICD-10 Finland

Malaise and fatigue

1.5

183.0

6987

43129

N06AX11

ATC

mirtazapine; oral

1.4

182.9

10138

67345

WX402

NOMESCO Finland

General anaesthesia

1.5

182.3

6233

37565

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.8

181.7

3136

15869

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.8

181.3

3116

15747

C10AA05

ATC

atorvastatin; oral

1.4

181.0

14021

98781

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.5

180.3

7440

46647

G47.3

ICD-10 Finland

Sleep apnoea

1.5

179.6

7008

43430

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.5

179.6

8041

51244

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.7

179.4

3982

21618

Z3231

NOMESCO Finland

Registered nurse

1.5

179.2

8428

54224

C08CA01

ATC

amlodipine; oral

1.4

179.2

12776

88686

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.8

178.5

3327

17211

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.5

178.2

8239

52820

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.4

176.1

1269

4645

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.5

174.6

5789

34611

Z3226

NOMESCO Finland

Physiotherapist

1.6

172.8

5545

32903

ZXE20

NOMESCO Finland

More than three and less than five hours

1.6

172.7

4301

24034

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

171.9

12036

83109

SPAT1263

SPAT

Sampling

1.4

171.3

12390

86016

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.6

169.0

4802

27692

TJX00

NOMESCO Finland

Punkture or biopsy in gastrointestinal endoscopy

34.3

167.1

118

I84.5

ICD-10 Finland

External hemorrhoids without complication

2.6

167.0

1023

3465

L17

ICPC

Foot/toe symptom/complaint

1.4

165.9

8626

56408

R03BB04

ATC

tiotropium bromide; inhalant

1.7

165.3

3423

18214

C10AA01

ATC

simvastatin; oral

1.4

164.5

14326

102342

J01AA02

ATC

doxycycline; systemic

1.4

163.8

24563

191786

JFB47

NOMESCO Finland

Laparoscopic resection of sigmoid colon

3.8

163.7

520

1189

K59.0

ICD-10 Finland

Constipation

2.0

162.9

1837

8071

D06

ICPC

Abdominal pain localized other

1.9

162.9

2454

11894

J01MA12

ATC

levofloxacin; systemic

1.5

162.5

5921

36066

ZXE10

NOMESCO Finland

More than one and less than three hours

1.4

161.7

10988

75269

A10BA02

ATC

metformin; oral

1.4

160.6

9153

60790

A02BA02

ATC

ranitidine; systemic

1.5

159.6

6118

37643

XF400

NOMESCO Finland

ECG with 12 standard connections

1.6

158.6

4977

29324

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.5

158.5

7508

48171

J01CA04

ATC

amoxicillin; systemic

1.4

158.2

24520

191779

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

157.9

5842

35673

I50.9

ICD-10 Finland

Heart failure, unspecified

1.6

157.1

4643

26981

K29.3

ICD-10 Finland

Chronic superficial gastritis

2.4

156.3

1124

4108

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

2.6

156.1

987

3395

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.6

155.6

4465

25763

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.5

155.3

4980

29472

T90

ICPC

Diabetes non-insulin dependent

1.4

155.2

7768

50323

A07EA06

ATC

budesonide; oral, local oral

2.4

154.0

1131

4173

K30

ICD-10 Finland

Functional dyspepsia

1.7

153.5

3265

17477

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.4

153.0

10365

70799

L01BC06

ATC

capecitabine; oral

2.2

151.9

1341

5357

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.5

151.5

5931

36600

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.9

151.3

2152

10232

R42

ICD-10 Finland

Dizziness and giddiness

1.5

151.2

7089

45325

207

Kela drug reimbursment

Chronic arrhythmias

1.5

150.4

5263

31722

K62.0

ICD-10 Finland

Anal polyp

4.3

149.6

412

847

L03

ICPC

Low back symptom/complaint

1.4

149.1

7732

50355

103

Kela drug reimbursment

Diabetes, insulin-treated

1.4

147.6

8608

57228

K51.5

ICD-10 Finland

Left sided colitis

2.7

147.3

820

2644

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.9

147.1

2120

10119

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.5

147.1

5801

35827

C18.21

ICD-10 Finland

Malignant tumor of the ascending colon invasive carcinoma

4.4

146.0

389

779

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.7

145.2

3041

16198

JFB21

NOMESCO Finland

Laparoscopic ileocaecal resection

16.2

144.9

134

B01AA03

ATC

warfarin; systemic

1.5

144.8

6267

39413

D11

ICPC

Diarrhoea

1.7

144.3

2921

15416

N05CF01

ATC

zopiclone; oral

1.4

143.0

10008

68544

UJF34

NOMESCO Finland

Left colonoscopy

4.9

142.8

333

597

XF402

NOMESCO Finland

ECG with work load test

1.6

142.3

3445

19047

N03AX12

ATC

[U] gabapentin; oral

1.5

140.0

4904

29519

A06AC51

ATC

ispaghula, combinations; oral

2.0

139.9

1533

6657

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

2.5

139.7

917

3211

ZXA00

NOMESCO Finland

Right side

1.4

139.6

8256

54918

N40

ICD-10 Finland

Hyperplasia of prostate

1.4

139.5

7140

46296

SPAT1153

SPAT

Removal of sutures

1.4

138.5

9783

67018

R51.80

ICD-10 Finland

Headache

1.6

138.5

3906

22400

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

138.5

14826

108293

R02

ICPC

Shortness of breath/dyspnoea

1.6

137.1

3937

22667

JG1CG

NOMESCO Finland

Extensive MRI of rectum

5.5

136.2

279

445

WX892

NOMESCO Finland

Monitored bed care

1.8

135.5

2377

12040

I84

ICD-10 Finland

Hemorrhoids

2.5

135.4

888

3107

I84.1

ICD-10 Finland

Internal hemorrhoids with other complications

2.7

135.1

784

2582

H02AB07

ATC

prednisone; oral

1.6

135.1

4198

24600

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.6

135.1

3418

19091

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.3

134.4

13121

94386

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.2

134.2

1251

5105

ZX120

NOMESCO Finland

Intravenous

1.7

133.3

2873

15403

C18.01

ICD-10 Finland

Malignant tumor of the caecum invasive carcinoma

4.0

133.2

395

859

JG1BG

NOMESCO Finland

MRI of rectum

4.9

132.3

306

545

E0000UV, ,

ATC

1.3

132.2

11860

84182

M04AA01

ATC

allopurinol; systemic

1.5

129.9

4248

25157

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.4

127.8

7212

47460

A04

ICPC

Weakness/tiredness general

1.5

127.7

4066

23931

A98

ICPC

Health maint/preventive medicine

1.7

127.7

30728

253890

M25.5

ICD-10 Finland

Pain in joint

1.4

127.4

8749

59489

C01DA14

ATC

isosorbide mononitrate; oral

1.5

126.9

5043

31088

JGB00

NOMESCO Finland

Partial proctectomy and colorectal or coloanal anastomosis

5.7

126.6

249

382

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.6

124.7

3203

17934

B01AF02

ATC

apixaban; oral

1.5

124.6

4107

24348

M48.0

ICD-10 Finland

Spinal stenosis

1.5

124.3

4004

23618

C18.00

ICD-10 Finland

Malignant tumor of the caecum without histology

4.3

123.8

336

683

JHB00

NOMESCO Finland

Hemorrhoidectomy

2.3

123.7

1023

3973

D18

ICPC

Change in faeces/bowel movements

2.6

123.6

777

2663

ZXA05

NOMESCO Finland

Left side

1.4

123.6

7639

51006

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.5

122.9

4854

29867

A10BH01

ATC

sitagliptin; oral

1.6

122.5

3038

16862

ZXD05

NOMESCO Finland

Urgent procedure

1.4

122.5

8521

57985

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.4

122.2

7749

51939

JFG10

NOMESCO Finland

Closure of loop colostomy without resection

3.8

122.2

392

903

8140/3-C18.9

ICD-O-3

Adenocarcinoma, NOS, of colon, NOS

5.9

121.4

231

343

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.3

121.4

1009

3927

R19.4

ICD-10 Finland

Change in bowel habit

2.4

120.2

875

3213

UJF30, ,

SPAT

4.1

120.1

348

744

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.6

119.9

3505

20218

UJD02

NOMESCO Finland

Gastroscopy

1.9

119.5

1500

6829

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.5

119.2

4905

30410

R60.0

ICD-10 Finland

Localized oedema

1.5

118.5

3771

22166

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.5

118.2

4139

24830

M54.4

ICD-10 Finland

Lumbago with sciatica

1.5

115.3

4913

30646

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.8

115.1

1874

9271

C10AC01

ATC

colestyramine; oral

2.4

114.8

857

3183

R07.3

ICD-10 Finland

Other chest pain

1.6

114.6

2995

16823

K57

ICD-10 Finland

Diverticular disease of intestine

2.6

114.6

714

2437

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.8

114.4

2060

10496

C18.20

ICD-10 Finland

Malignant tumor of the ascending colon without histology

4.2

114.2

324

682

K57.9

ICD-10 Finland

Diverticular disease of intestine, part unspecified, without perforation or abscess

2.5

114.0

791

2841

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.6

113.6

3151

17946

J01DA01

ATC

[U] cefalexin

1.3

113.0

18279

139732

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.4

112.8

7724

52299

J01FA06

ATC

roxithromycin; oral

1.3

112.0

11531

82915

R52.9

ICD-10 Finland

Pain, unspecified

1.6

110.7

2764

15347

A03FA01

ATC

metoclopramide; systemic, rectal

1.4

110.4

6356

41811

JFB44

NOMESCO Finland

Laparoscopic left hemicolectomy

5.7

110.3

218

336

SPAT1104

SPAT

Monitoring of emergency patient

1.7

110.0

1976

10058

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.0

110.0

1369

6212

C03DA01

ATC

spironolactone; oral

1.5

109.3

3728

22214

R01AD09

ATC

mometasone; nasal

1.3

108.3

12253

89132

B82

ICPC

Anaemia other/unspecified

2.3

108.0

871

3345

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.3

107.6

9275

64943

SPAT1301

SPAT

No procedures

1.3

107.4

9122

63726

D12

ICPC

Constipation

2.1

107.3

1106

4689

J01FF01

ATC

clindamycin; systemic

1.4

106.2

7831

53550

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.5

106.1

3435

20232

SAA01

NOMESCO Finland

Simple examination of mouth

1.3

105.8

20155

156729

D50.8

ICD-10 Finland

Other iron deficiency anaemias

3.0

105.7

490

1429

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

1.9

105.6

1369

6296

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.3

105.6

8302

57311

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.3

105.2

15545

116956

R03BA02

ATC

budesonide; inhalant

1.4

104.9

4846

30634

J45.1

ICD-10 Finland

Nonallergic asthma

1.7

104.7

2037

10599

R31

ICD-10 Finland

Unspecified haematuria

1.5

104.0

3184

18523

N06AX21

ATC

duloxetine; oral

1.5

103.6

3123

18106

B80

ICPC

Iron deficiency anaemia

2.5

103.3

683

2399

G04BD12

ATC

mirabegron; oral

1.5

103.1

3636

21798

C209, 8211, 2

ICD-O-3

27.9

102.8

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.7

102.7

2135

11308

A07EA02

ATC

hydrocortisone; rectal

2.5

102.3

662

2301

GD1AD

NOMESCO Finland

Thorax CT examination

1.8

102.1

1749

8775

R35

ICD-10 Finland

Polyuria

1.7

101.7

2059

10826

L04AX01

ATC

azathioprine; systemic

2.0

101.1

1178

5221

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.4

100.9

5203

33521

G44.2

ICD-10 Finland

Tension-type headache

1.5

100.7

3432

20422

WX320

NOMESCO Finland

Spinalanesthesy

1.4

100.2

7121

48344

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

100.2

10956

79096

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.7

99.8

2157

11539

ZXE00

NOMESCO Finland

One hour or less

1.3

99.7

11000

79494

K64.1

ICD-10 Finland

Second degree haemorrhoids

2.5

99.3

631

2174

G04CB01

ATC

finasteride; oral

1.5

99.3

3506

21014

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.4

98.6

710

2594

A01

ICPC

Pain general/multiple sites

1.6

98.5

2555

14300

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

2.1

98.2

1026

4370

WZA90

NOMESCO Finland

Other medical or dental certificate

1.4

98.0

6159

40993

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.5

98.0

4004

24706

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.7

97.6

1835

9452

A28

ICPC

Limited function/disability NOS

1.4

97.2

5177

33517

JFF23

NOMESCO Finland

Transversostomy

3.2

97.1

411

1136

R50.9

ICD-10 Finland

Fever, unspecified

1.5

97.0

4065

25197

M10.9

ICD-10 Finland

Gout, unspecified

1.7

96.5

2142

11535

R05

ICD-10 Finland

Cough

1.4

96.4

5918

39227

SFA10

NOMESCO Finland

One-surface restoration

1.3

96.4

14930

112502

130

Kela drug reimbursment

Malignant tumour

1.6

95.7

2713

15499

JFB46

NOMESCO Finland

Resection of sigmoid colon

3.1

95.4

415

1166

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.6

95.3

2768

15897

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

2.3

95.3

748

2839

JGA75

NOMESCO Finland

Endoscopic microsurgical excision of lesion of rectum

133.1

95.3

107

R13

ICD-10 Finland

Dysphagia

1.7

94.9

2015

10725

XF404

NOMESCO Finland

Ambulatory ECG

1.6

93.5

2607

14832

Z71.8

ICD-10 Finland

Other specified counselling

1.3

93.5

8047

56099

Z01.7

ICD-10 Finland

Laboratory examination

1.5

93.4

3892

24085

N05BA04

ATC

oxazepam; oral

1.3

93.2

7155

49057

R11

ICD-10 Finland

Nausea and vomiting

1.6

92.9

2245

12344

A11

ICPC

Chest pain NOS

1.6

92.7

2395

13384

K78

ICPC

Atrial fibrillation/flutter

1.6

92.7

2418

13545

H02AB04

ATC

methylprednisolone; systemic

1.4

92.6

4107

25714

H25.1

ICD-10 Finland

Senile nuclear cataract

1.3

92.6

8428

59202

Z09.8

ICD-10 Finland

Follow-up examination after other treatment for other conditions

2.2

92.5

830

3332

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.6

91.7

2351

13114

SPAT1254

SPAT

Administration of medicine

1.4

91.5

4154

26115

SPAT1325

SPAT

Vaccination

1.3

91.4

9702

69551

C18.79

ICD-10 Finland

Malignant tumor of the sigmoid or other unspecified histology

5.4

91.3

190

308

B01AC04

ATC

clopidogrel; oral

1.4

91.2

5130

33480

SPAT1262

SPAT

Handing over of treatment supplies

1.4

91.1

5227

34227

A10BH05

ATC

linagliptin; oral

1.8

91.1

1606

8121

JFB51

NOMESCO Finland

Other laparoscopic resection of colon

17.6

91.0

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.4

90.8

4002

25022

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

1.8

90.6

1406

6846

N17

ICPC

Vertigo/dizziness

1.5

90.6

3428

20813

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.4

90.4

5047

32891

D64.8

ICD-10 Finland

Other specified anaemias

2.5

90.0

585

2038

JF2BD

NOMESCO Finland

Extensive colon CT

3.4

89.7

334

852

WX722

NOMESCO Finland

PEEP

1.8

89.6

1387

6748

R63.4

ICD-10 Finland

Abnormal weight loss

1.9

89.4

1147

5254

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.4

89.3

4930

32061

J45

ICD-10 Finland

Asthma

1.5

88.9

2695

15615

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.5

88.9

3747

23222

A02BC04

ATC

rabeprazole; oral

1.6

88.8

2340

13135

8140/3-C18.2

ICD-O-3

Adenocarcinoma, NOS, of ascending colon

4.1

88.7

256

546

C20.99

ICD-10 Finland

Malignant tumor of the rectum other or unspecified histology

4.4

88.6

236

473

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.4

88.4

3950

24750

Z93.3

ICD-10 Finland

Colostomy status

3.6

88.0

307

750

XCK10

NOMESCO Finland

Photography of fundus of eye

1.5

87.9

2822

16557

R15

ICD-10 Finland

Faecal incontinence

2.1

87.8

853

3534

M03BX02

ATC

tizanidine; oral

1.3

87.8

17732

137265

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.3

87.3

7009

48295

K51.3

ICD-10 Finland

Ulcerative (chronic) rectosigmoiditis

2.6

87.2

522

1747

SPAT1097

SPAT

Recording of ECG

1.4

87.0

4389

28095

L82

ICD-10 Finland

Seborrhoeic keratosis

1.4

86.8

5268

34784

M79.1

ICD-10 Finland

Myalgia

1.5

86.2

3580

22116

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.4

86.2

5495

36559

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

2.1

86.1

895

3805

N06AB04

ATC

citalopram; systemic

1.4

85.6

5710

38258

J02AC01

ATC

fluconazole; systemic

1.3

85.5

10181

73920

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

2.4

85.3

624

2296

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.4

84.8

4740

30865

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.5

84.6

3142

18988

K02.1

ICD-10 Finland

Caries of dentine

1.3

84.5

15672

119887

R96

ICPC

Asthma

1.5

84.3

2617

15234

JGB07

NOMESCO Finland

Laparoscopic partial proctectomy with total excision of mesorectum

5.2

84.3

181

302

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

2.6

84.0

502

1678

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.7

84.0

1776

9433

A07AA02

ATC

nystatin; oral

1.7

84.0

1719

9053

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.4

83.9

5309

35266

K64.2

ICD-10 Finland

Third degree haemorrhoids

2.9

83.7

423

1295

3AC01, ,

NOMESCO Finland

3.3

83.3

323

846

G04CA01

ATC

alfuzosin; oral

1.4

83.2

3756

23556

SPAT1312

SPAT

General health counselling

1.3

83.2

8397

59641

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.4

82.9

3601

22426

K64.8

ICD-10 Finland

Other specified haemorrhoids

3.6

82.4

288

705

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.6

82.1

2143

11992

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.4

82.1

3442

21290

B01AB10

ATC

tinzaparin; parenteral

1.5

82.1

2848

16972

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.6

82.0

2199

12384

R19.5

ICD-10 Finland

Other faecal abnormalities

2.6

81.9

483

1604

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

1.5

81.9

3113

18894

JFB43

NOMESCO Finland

Left hemicolectomy

4.0

81.8

242

526

-60

ICPC

Result test/procedure

1.7

81.8

1601

8329

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.6

81.8

2340

13374

D02

ICPC

Abdominal pain epigastric

1.7

81.8

1565

8093

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.3

81.6

5884

39853

C09CA01

ATC

losartan; oral

1.3

81.6

7778

54800

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.6

81.5

2048

11357

A10AE04

ATC

insulin glargine; parenteral

1.5

81.5

2715

16042

C187, 8211, 2

ICD-O-3

22.1

81.3

S29

ICPC

Skin symptom/complaint other

1.4

81.2

5303

35378

NF1AA

NOMESCO Finland

Hip X-ray examination

1.5

81.0

2630

15455

Z51.4

ICD-10 Finland

Preparatory care for subsequent treatment, not elsewhere classified

3.4

80.8

307

794

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.5

80.8

2688

15877

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.3

80.6

12615

94455

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

1.9

80.6

1016

4625

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.4

80.4

3509

21862

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.3

80.0

12067

89941

SAA02

NOMESCO Finland

Basic examination of mouth

1.2

79.9

17783

138473

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.5

79.9

2782

16584

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.3

79.9

7208

50382

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.5

79.7

3052

18543

A02BD07

ATC

lansoprazole, amoxicillin and clarithromycin; systemic

1.8

79.3

1394

7039

R03AC03

ATC

terbutaline; inhalant

1.4

78.9

3608

22666

R06AE07

ATC

cetirizine; oral

1.3

78.9

11697

86970

Z01.2

ICD-10 Finland

Dental examination

1.3

78.9

11826

88043

D07AC01

ATC

betamethasone; topical

1.3

78.7

10253

75077

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.5

78.6

3041

18511

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.3

78.6

7182

50267

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.3

77.4

8260

58982

C18.41

ICD-10 Finland

Malignant tumor of the transverse colon invasive carcinoma

4.9

77.2

179

320

JGB06

NOMESCO Finland

Partial proctectomy with total excision of mesorectum

4.2

77.2

214

443

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.3

77.1

8273

59109

205

Kela drug reimbursment

Chronic hypertension

1.3

76.9

8421

60315

L01

ICPC

Neck symptom/complaint

1.4

76.9

3897

24921

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.4

76.9

4537

29760

M02AA07

ATC

piroxicam; topical

1.3

76.8

10642

78437

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.5

76.8

2277

13114

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.4

76.6

4215

27332

D75

ICPC

Malignant neoplasm colon/rectum

3.4

76.5

290

749

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

76.4

10823

79963

E66.01

ICD-10 Finland

Obesity due to excess calories

1.6

76.3

2004

11226

K96

ICPC

Haemorrhoids

2.2

76.1

713

2912

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.6

75.9

2111

11981

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

75.6

9874

72230

A03FA02

ATC

cisapride; oral, rectal

1.6

75.6

2136

12169

R01AD08

ATC

fluticasone; nasal

1.3

75.4

7370

51997

H04.10

ICD-10 Finland

Dry eye syndrome

1.5

75.2

3007

18413

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.3

75.2

5301

35729

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

1.7

74.8

1402

7206

K29.8

ICD-10 Finland

Duodenitis

3.2

74.7

304

821

C209, 8148, 2

ICD-O-3

14.0

74.3

C09AA05

ATC

ramipril; oral

1.3

74.3

7677

54537

8140/3-C18.0

ICD-O-3

Adenocarcinoma, NOS, of cecum

3.8

74.2

236

541

A03CA02

ATC

clidinium and psycholeptics; oral

1.6

74.1

1703

9236

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.2

74.0

667

2683

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.6

73.9

1688

9139

K55.8

ICD-10 Finland

Other vascular disorders of intestine

4.4

73.8

194

385

M03BC51

ATC

orphenadrine, combinations; systemic

1.3

73.8

7257

51218

8240/3-C20.9

ICD-O-3

Neuroendocrine tumor, NOS, of rectum, NOS

17.4

73.7

N06AX16

ATC

venlafaxine; oral

1.4

73.6

3332

20877

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.3

73.6

10001

73449

R03DC03

ATC

montelukast; oral

1.4

73.5

4131

26868

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

1.8

73.4

1150

5611

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.5

73.3

2510

14899

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.5

73.3

2741

16562

TJF80

NOMESCO Finland

Ostomy education

2.9

73.2

361

1091

R33

ICD-10 Finland

Retention of urine

1.5

73.2

2354

13793

XJH00

NOMESCO Finland

Transanal ultrasonography

1.6

73.1

1799

9920

J20

ICD-10 Finland

Acute bronchitis

1.5

72.8

2644

15884

U02

ICPC

Urinary frequency/urgency

1.4

72.5

3717

23799

H25.8

ICD-10 Finland

Other senile cataract

1.4

72.0

3258

20405

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.2

72.0

11115

82774

N05CF02

ATC

zolpidem; oral

1.4

71.9

4571

30306

R03AK07

ATC

formoterol and budesonide; inhalant

1.3

71.9

5314

36044

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

2.3

71.6

566

2155

J01EA01

ATC

trimethoprim; systemic

1.3

71.2

6988

49271

U07

ICPC

Urine symptom/complaint other

1.6

71.1

2055

11760

JAH01

NOMESCO Finland

Laparoscopy

1.8

71.1

1091

5290

B01AF01

ATC

rivaroxaban; oral

1.4

70.9

3776

24329

SPAT1053

SPAT

Memory test

1.4

70.8

4352

28700

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

1.5

70.3

2404

14263

KE1BE

NOMESCO Finland

Rectal ultrasound examinaiton of prostata

1.5

70.2

2515

15065

M03BC01

ATC

orphenadrine (citrate); systemic

1.3

70.1

5692

39106

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

1.6

70.0

1546

8297

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.4

70.0

3703

23829

A08

ICPC

Swelling

1.7

69.5

1444

7627

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

2.1

69.4

667

2752

L05

ICPC

Flank/axilla symptom/complaint

1.6

69.4

1590

8614

C19

ICD-10 Finland

Malignant neoplasm of rectosigmoid junction

3.8

69.3

220

504

R5110, ,

SPAT

1.6

69.2

1871

10546

2113X

ICD-9 Finland

Benign neoplasm of other parts of digestive system, Colon[NEOPLASMA BENIGNUM ALIUD COLI]

+∞

69.0

2113C

ICD-9 Finland

Benign neoplasm of other parts of digestive system, Colon[ADENOMA TUBULARE COLI]

+∞

69.0

ZXA10

NOMESCO Finland

Bilateral

1.3

69.0

5231

35585

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.4

69.0

2981

18509

L13

ICPC

Hip symptom/complaint

1.3

68.8

5133

34835

JDA05

NOMESCO Finland

Endoscopic polypectomy in stomach or pylorus

4.3

68.6

183

368

N30.0

ICD-10 Finland

Acute cystitis

1.4

68.4

4154

27325

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.6

68.4

1510

8104

C10AA07

ATC

rosuvastatin; oral

1.3

68.3

9430

69242

N17.9

ICD-10 Finland

Acute renal failure, unspecified

1.7

68.2

1202

6070

N02AA05

ATC

oxycodone; systemic

1.3

68.2

5192

35335

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.3

68.2

6422

44998

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.4

68.1

4063

26655

JFA05

NOMESCO Finland

Endoscopic polypectomy in small intestine

16.1

67.9

K51.2

ICD-10 Finland

Ulcerative (chronic) proctitis

2.7

67.9

389

1274

K22.7

ICD-10 Finland

Barrett oesophagus

2.5

67.9

427

1465

R03BA05

ATC

fluticasone; inhalant

1.3

67.9

4645

31121

D07AB02

ATC

hydrocortisone butyrate; topical

1.3

67.7

7885

56735

-, ,

ICD-10 Finland

2.1

67.5

664

2764

N02BF02

ATC

pregabalin; oral

1.6

67.4

1500

8065

C18.61

ICD-10 Finland

Malignant tumor of the colon descending invasive carcinoma

5.7

67.1

131

200

A11CC03

ATC

alfacalcidol; systemic

2.1

67.0

671

2813

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.5

66.8

2002

11546

K60.1

ICD-10 Finland

Chronic anal fissure

2.2

66.7

602

2422

C18.99

ICD-10 Finland

Malignant tumor in unspecified location in the colon other or unspecified histology

5.1

66.6

148

255

C10AX09

ATC

ezetimibe; oral

1.3

66.6

4573

30646

SPAT1216

SPAT

Assessment of functional ability

1.3

66.4

4494

30047

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.6

66.3

1479

7955

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

1.7

66.3

1304

6787

N02BF01

ATC

gabapentin; oral

1.5

66.3

2120

12397

J01MA14

ATC

moxifloxacin; systemic

1.5

66.1

2441

14700

N01

ICPC

Headache

1.5

66.0

2082

12138

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.5

65.9

2216

13094

N06AA09

ATC

amitriptyline; systemic

1.5

65.9

2675

16409

1381

FHL

Colonoscopy and polyp removal

36.3

65.9

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.4

65.8

4255

28249

JN4CD

NOMESCO Finland

Very extensive body CT

1.8

65.3

1059

5220

A46

ICD-10 Finland

Erysipelas

1.4

65.2

4221

28027

C189, 8211, 2

ICD-O-3

29.8

65.2

K51.8

ICD-10 Finland

Other ulcerative colitis

2.7

65.1

369

1202

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.6

65.1

1552

8488

K57.2

ICD-10 Finland

Diverticular disease of large intestine with perforation and abscess

2.1

65.0

623

2567

C18.60

ICD-10 Finland

Malignant tumor of the descending colon without histology

6.6

65.0

110

145

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.3

64.8

5521

38132

I48.1

ICD-10 Finland

Persistent atrial fibrillation

1.7

64.5

1196

6127

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

1.7

64.5

1129

5691

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.4

64.4

2655

16330

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.7

64.4

1332

7027

JFG00

NOMESCO Finland

Closure of loop enterostomy without resection

3.9

64.3

196

436

S21

ICPC

Skin texture symptom/complaint

1.4

64.2

3823

25051

A02BD03

ATC

lansoprazole, amoxicillin and metronidazole; systemic

1.5

64.2

1945

11241

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.4

64.2

3155

20029

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

2.5

64.2

414

1438

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.3

64.1

6427

45346

TKC20

NOMESCO Finland

Catheterisation of bladder

1.5

64.0

1955

11318

R04.2

ICD-10 Finland

Haemoptysis

1.8

64.0

979

4741

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

1.8

64.0

1010

4938

C09CA06

ATC

candesartan; oral

1.3

64.0

6586

46620

K22.1

ICD-10 Finland

Ulcer of oesophagus

2.3

63.6

525

2037

X59

ICD-10 Finland

Exposure to unspecified factor

1.3

63.5

4949

33754

L08

ICPC

Shoulder symptom/complaint

1.3

63.3

5955

41658

M01AE02

ATC

naproxen; oral, rectal

1.2

63.2

15480

120430

K25.9

ICD-10 Finland

Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation

2.2

63.1

546

2161

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

63.0

18825

149334

D50

ICD-10 Finland

Iron deficiency anaemia

2.3

62.9

516

1997

I85.9

ICD-10 Finland

Oesophageal varices without bleeding

3.0

62.8

293

859

R05

ICPC

Cough

1.3

62.8

6205

43681

M01AH05

ATC

etoricoxib; oral

1.2

62.7

17563

138409

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.5

62.6

2124

12571

8140/3-C18.4

ICD-O-3

Adenocarcinoma, NOS, of transverse colon

5.1

62.4

138

237

E66.00

ICD-10 Finland

Metabolic syndrome

1.6

62.4

1465

7982

J01FA10

ATC

azithromycin; systemic

1.2

62.3

15096

117251

Z2446

NOMESCO Finland

Social worker

1.6

62.3

1508

8276

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

62.1

6500

46083

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

1.6

62.0

1408

7606

R19.8

ICD-10 Finland

Other specified symptoms and signs involving the digestive system and abdomen

2.5

61.9

405

1416

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

1.7

61.8

1100

5569

SPAT1255

SPAT

Intravenous administration of medicine

1.5

61.6

1860

10740

8140/3-C19.9

ICD-O-3

Adenocarcinoma, NOS, of rectosigmoid junction

4.6

61.6

154

294

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

1.8

61.5

916

4400

I50.0

ICD-10 Finland

Congestive heart failure

1.5

61.5

2164

12903

WX290

NOMESCO Finland

Other blockage of nerve

1.2

61.3

11132

83949

A10BB12

ATC

glimepiride; oral

1.5

61.3

1969

11519

SFA20

NOMESCO Finland

Two-surface restoration

1.2

61.1

15574

121470

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.5

61.1

1850

10687

N19

ICD-10 Finland

Unspecified kidney failure

1.8

60.9

1020

5076

R04.0

ICD-10 Finland

Epistaxis

1.5

60.7

2113

12568

JFB54

NOMESCO Finland

Laparoscopic resection of sigmoid colon with partial proctectomy

6.4

60.6

105

142

A97

ICPC

No disease

1.3

60.4

4597

31227

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.6

60.4

1439

7867

ZXE30

NOMESCO Finland

More than five and less than seven hours

1.6

60.2

1319

7061

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.2

60.2

11809

89713

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.4

60.2

2988

18991

2114X

ICD-9 Finland

Benign neoplasm of other parts of digestive system, Rectum and anal canal[NEOPLASMA BENIGNUM ALIUD RECTI ET CANALIS ANALIS]

+∞

60.2

C08CA13

ATC

lercanidipine; oral

1.3

60.1

4215

28298

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

2.1

60.0

609

2566

G04CA52

ATC

tamsulosin and dutasteride; systemic

1.4

60.0

2924

18525

J31.0

ICD-10 Finland

Chronic rhinitis

1.5

59.9

2002

11808

N06AB10

ATC

escitalopram; oral

1.3

59.8

4603

31311

A10BK03

ATC

empagliflozin; oral

1.4

59.8

2673

16679

P20

ICPC

Memory disturbance

1.3

59.5

3921

26078

SPAT1260

SPAT

Consultation of another employee

1.3

59.4

4784

32745

L15

ICPC

Knee symptom/complaint

1.3

59.4

6411

45587

M70.6

ICD-10 Finland

Trochanteric bursitis

1.4

59.0

3520

23050

M54

ICD-10 Finland

Dorsalgia

1.4

59.0

2862

18112

TJG20

NOMESCO Finland

Transanal irrigation

6.6

59.0

100

132

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.5

58.6

1759

10139

K58

ICD-10 Finland

Irritable bowel syndrome

2.1

58.6

575

2391

WYA10

NOMESCO Finland

Emergency care or similar visit

1.5

58.4

1715

9838

K29.4

ICD-10 Finland

Chronic atrophic gastritis

2.1

58.4

616

2633

K50.8

ICD-10 Finland

Other Crohn disease

2.6

58.4

361

1229

M01AX17

ATC

nimesulide; oral

1.3

58.3

6904

49619

A10AB05

ATC

insulin aspart; parenteral

1.5

58.3

1981

11725

C18.51

ICD-10 Finland

Malignant tumor of flexura hiealis invasive carcinoma

6.1

58.2

106

151

J01FA09

ATC

clarithromycin; systemic

1.2

58.2

8108

59364

K62.6

ICD-10 Finland

Ulcer of anus and rectum

3.0

58.1

263

758

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.5

58.0

2074

12400

A09AA02

ATC

multienzymes (lipase, protease etc.); oral

2.0

57.8

647

2826

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

1.8

57.7

924

4538

R4190

NOMESCO Finland

Nutritional therapy

1.8

57.6

862

4147

N18.8

ICD-10 Finland

Other chronic renal failure

1.9

57.5

717

3251

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.9

57.5

804

3786

Z98.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3030467) Casts [#/volume] in Urine by Automated count

11050

68502

1.60

315.60

3.8

3.2

0.44

e6/l

0.09

8593

52399

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

2835

11068

2.34

307.65

1.7

1.6

1.58

1.57

g/l

0.10

2454

9369

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

7193

32854

2.15

307.65

3.2

2.5

20.75

22.62

22.97

6249

27773

(3007164) IgA [Mass/volume] in Serum or Plasma

7926

39047

2.00

307.65

1.5

2.59

2.55

g/l

0.70

4490

23165

(3022096) Basophils/100 leukocytes in Blood

16468

106604

1.68

307.65

7.0

6.0

0.68

0.67

0.31

15349

99055

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

13600

75785

1.94

307.65

3.0

2.5

61.38

63.46

u/l

0.41

12669

69634

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

27222

186541

2.48

307.65

9.7

7.6

79.67

79.50

u/l

0.21

26013

175210

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

4067

17539

2.15

307.65

1.7

1.6

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

30999

246171

2.40

307.65

25.8

17.4

139.63

139.68

mmol/l

2.78

30511

239903

(3022145) Colonoscopy Study observation

12156

20826

7.41

307.65

1.5

1.3

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

12526

75017

1.72

307.65

3.4

3.0

1641.28

1473.99

ng/l

2.81

10906

64477

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

3384

12613

2.48

307.65

2.6

2.4

—

(40768804) Tissue Pathology biopsy report

16228

94853

1.95

307.65

2.5

2.1

—

(3027945) Reticulocytes/100 erythrocytes in Blood

5898

27849

2.02

307.65

2.5

2.4

1.80

1.77

1.44

5207

24507

(3001604) Monocytes [#/volume] in Blood

18535

116826

1.85

307.65

6.7

5.7

0.60

e9/l

0.66

16053

100396

(40760892) CBC W Ordered Manual Differential panel - Blood

17461

109965

1.80

307.65

7.1

6.4

—

(3018010) Neutrophils/100 leukocytes in Blood

17082

111160

1.69

307.65

6.9

5.9

58.37

57.67

11.13

15966

103790

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

20873

126550

2.16

307.65

7.0

6.3

11.28

11.73

umol/l

5.79

19939

120012

(3013115) Eosinophils [#/volume] in Blood

19084

120802

1.87

307.65

7.0

6.0

0.19

0.20

e9/l

1.14

16712

105162

(3031040) Bacteria [#/volume] in Urine by Automated count

22987

156743

1.89

307.65

5.7

4.5

490.71

1488.97

e6/l

4.48

195

2477

(3023520) Reticulocytes [#/volume] in Blood

4483

20959

1.99

307.65

2.6

69.92

69.01

e9/l

0.92

3436

15952

(3022217) INR in Platelet poor plasma by Coagulation assay

18633

119282

1.81

307.65

20.4

15.6

1.33

1.30

inr

3.02

4316

34558

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

10380

57325

1.83

307.65

2.8

2.4

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

5456

26808

1.92

307.65

3.0

2.7

7.85

9.46

umol/l

6.84

4804

23308

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

14734

96972

1.57

307.65

2.6

2.2

78.24

1031.93

nmol/l

0.50

13091

86027

(3018095) Leukocytes [#/volume] in Urine

13432

85732

1.60

307.65

4.6

3.7

82.25

111.28

e6/l

4.67

9809

61637

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

7092

25063

2.85

307.65

4.5

3.9

16.21

27.81

ug/l

1.59

5908

20429

(3022948) Iron [Moles/volume] in Serum or Plasma

8045

37686

2.13

307.65

3.1

2.5

11.95

12.85

umol/l

23.33

7569

34853

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

19256

124159

1.82

307.65

8.5

6.6

1.21

mmol/l

15.89

17023

104480

(3044640) Blood type and Crossmatch panel - Blood

13179

75218

1.86

307.65

2.9

2.4

—

(3023368) Bacteria identified in Blood by Culture

11431

68706

1.68

307.65

4.9

4.3

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

17533

110656

1.80

307.65

3.0

2.6

—

(40768797) Stomach Pathology biopsy report

7621

31854

2.40

307.65

1.3

1.2

—

(3013707) Erythrocyte sedimentation rate by Westergren method

25331

175529

2.07

307.65

5.1

4.1

13.99

13.08

mm/h

15.89

23516

161512

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

12066

58521

2.24

307.65

2.8

2.2

3.25

2.98

mg/l

22.04

10508

49584

(3023103) Potassium [Moles/volume] in Serum or Plasma

31019

246776

2.38

307.65

26.0

17.5

3.98

mmol/l

0.18

30498

240104

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

17887

112675

1.82

307.65

7.3

6.0

1.21

mmol/l

9.24

16453

102254

(3006504) Eosinophils/100 leukocytes in Blood

16947

109893

1.69

307.65

7.0

6.0

2.82

2.87

2.28

15816

102331

(3013826) Glucose [Moles/volume] in Serum or Plasma

21264

143384

1.80

307.65

5.9

4.7

6.86

6.80

mmol/l

4.14

20209

134990

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

4715

22726

1.93

307.65

2.6

2.2

0.22

0.21

g/l

9.69

4419

20989

(3015377) Calcium [Moles/volume] in Serum or Plasma

12948

82705

1.59

307.65

3.6

3.4

2.35

2.36

mmol/l

2.92

11176

72108

(3033658) Prothrombin time (PT) actual/Normal

10657

61169

1.75

307.65

5.1

3.9

88.13

88.64

1.16

10430

59668

(40758558) Short blood count panel - Blood

9968

59678

1.64

307.65

7.3

7.0

—

(3015736) pH of Urine

14275

92304

1.60

307.65

4.3

3.5

5.83

5.80

0.43

677

5721

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

30405

233816

2.52

307.65

22.1

15.0

25.42

25.04

mg/l

1.17

26122

187157

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

20946

148694

1.60

307.65

4.0

3.1

58.66

52.36

u/l

12.61

19437

137099

(3037467) Urinalysis macro (dipstick) panel - Urine

23534

163274

1.86

307.65

5.5

4.4

—

(3048689) Calprotectin [Mass/mass] in Stool

6429

23448

2.71

307.65

2.4

2.2

147.68

144.41

ug/g

0.22

5154

18369

(3011397) Hemoglobin [Presence] in Urine by Test strip

9306

54912

1.65

307.65

4.5

3.7

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

6285

31314

1.92

307.65

7.5

7.0

104.45

104.34

mmol/l

0.95

6280

31290

(3002030) Lymphocytes/100 leukocytes in Blood

17252

113031

1.68

307.65

7.2

6.1

26.45

27.20

15.01

16140

105640

(3019069) Monocytes/100 leukocytes in Blood

17014

110529

1.69

307.65

7.3

6.3

8.79

8.73

1.79

15902

103064

(3004789) Transferrin [Mass/volume] in Serum or Plasma

7543

34919

2.13

307.65

3.1

2.4

2.35

2.29

g/l

15.25

7050

32086

(3001122) Ferritin [Mass/volume] in Serum or Plasma

15995

92301

1.97

307.65

3.7

2.7

133.44

151.59

ug/l

10.05

14840

84262

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

17138

101235

1.97

307.65

2.3

2.0

94.95

95.24

pmol/l

0.32

9538

51865

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

27990

214582

1.84

307.65

5.5

4.7

2.02

2.12

mu/l

0.56

25715

194432

(3021960) Folate [Moles/volume] in Serum or Plasma

10225

57315

1.79

307.65

1.7

1.5

20.62

20.38

nmol/l

0.67

8863

48555

(3019198) Lymphocytes [#/volume] in Blood

18876

119830

1.85

307.65

6.8

5.8

1.86

1.91

e9/l

2.03

16674

105194

(3013650) Neutrophils [#/volume] in Blood by Automated count

20960

135674

1.92

307.65

9.9

9.1

4.22

4.17

e9/l

2.41

18322

117995

(3006315) Basophils [#/volume] in Blood

18608

117140

1.86

307.65

6.7

5.8

0.04

e9/l

0.34

16097

100603

(3019309) Folate [Moles/volume] in Red Blood Cells

8626

47509

1.78

307.65

1.8

1123.05

1172.29

nmol/l

4.97

6597

35597

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

14684

95557

1.60

307.65

4.5

3.7

42.18

70.15

ng/l

4.03

10988

68990

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

4592

21532

1.99

307.65

2.8

2.5

45.21

47.35

u/l

0.11

3927

18347

(3024561) Albumin [Mass/volume] in Serum or Plasma

18381

106135

2.13

307.65

6.0

4.7

35.14

35.10

g/l

0.36

17324

98013

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

7664

42008

1.76

307.65

3.2

2.8

1.14

1.21

e6/l

0.33

4660

24037

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

8866

44429

2.00

307.65

1.3

1.2

1.65

1.70

u/ml

0.11

2085

11706

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

11904

75463

1.58

306.87

3.6

3.2

34.47

34.95

u/l

0.16

11190

71303

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

23817

176590

1.60

302.78

4.4

4.0

14.98

14.91

pmol/l

4.29

21658

158971

(40761511) CBC panel - Blood by Automated count

30405

241563

2.10

300.10

21.1

14.2

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

6976

38992

1.70

296.73

3.4

3.0

2.48

2.58

e6/l

0.33

4027

21171

(3035350) Ketones [Presence] in Urine by Test strip

16817

115664

1.53

296.65

4.6

3.7

0.00

estimate

0.88

2553

23786

(3000570) Elastase.pancreatic [Mass/mass] in Stool

1924

6790

2.55

291.21

1.5

1.4

271.40

265.61

ug/g

0.57

1175

3983

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

5472

28786

1.78

287.68

3.9

4.3

237.73

246.92

u/l

2.62

5147

27167

(3009261) Glucose [Presence] in Urine by Test strip

16923

117064

1.52

286.43

4.7

3.8

0.00

estimate

0.08

2258

21714

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

28320

220694

1.77

282.97

7.5

6.0

40.91

40.26

mmol/mol

25.42

26368

202317

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

5508

29187

1.76

281.83

7.1

7.2

5.09

kpa

0.03

5266

27815

(36304419) Bacteria [Presence] in Urine

10561

66122

1.57

281.20

3.8

3.1

—

(3027801) Oxygen [Partial pressure] in Arterial blood

5503

29170

1.76

281.20

7.1

12.06

12.25

kpa

1.92

5252

27793

(3003396) Base excess in Arterial blood by calculation

5497

29166

1.76

279.82

7.1

0.95

1.12

mmol/l

2.23

4440

23371

(3021601) Nitrite [Presence] in Urine by Test strip

16719

115731

1.51

279.06

6.2

5.0

0.00

estimate

0.06

2366

22279

(3002582) Erythrocytes [#/volume] in Urine

11649

74837

1.54

274.80

4.0

3.3

75.33

100.76

e6/l

1.25

9108

57592

(3026008) Bacteria identified in Urine by Culture

11704

75316

1.54

273.71

3.6

3.2

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

5911

32210

1.72

273.07

7.3

5.5

1.05

1.03

mmol/l

5.22

5523

29825

(3026493) Urate [Moles/volume] in Serum or Plasma

10411

65344

1.56

272.10

3.1

2.7

4340.04

4933.05

umol/l

0.76

9096

56525

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

31049

250068

2.20

269.47

14.5

10.7

25.76

26.18

u/l

3.10

30276

240268

(3000991) Gas panel - Venous blood

4168

20587

1.87

267.65

8.6

8.1

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

4335

21804

1.83

262.35

7.0

6.8

1.34

1.37

mmol/l

0.99

4228

21209

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

11784

76464

1.52

262.09

2.3

2.1

193.06

213.44

u/l

1.85

11069

71394

(3021447) Carbon dioxide [Partial pressure] in Venous blood

4479

22783

1.82

261.23

4.8

3.7

5.80

5.83

kpa

1.36

4349

22134

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

2222

8792

2.28

260.46

3.4

768.56

1610.25

u/ml

1.07

1899

7538

(3016502) Oxygen saturation in Arterial blood

4974

26131

1.77

260.15

7.4

7.5

95.59

95.53

0.29

4829

25145

(3002032) Base excess in Venous blood by calculation

4456

22759

1.81

255.99

4.8

3.7

1.79

1.94

mmol/l

1.88

3810

19431

(3042936) Bacteria identified in Isolate by Culture

6165

34527

1.68

255.23

2.2

2.0

—

(3012544) pH of Venous blood

4580

23731

1.78

250.28

4.8

3.7

7.38

0.02

194

(3020564) Creatinine [Moles/volume] in Serum or Plasma

30979

250185

2.11

250.10

25.8

17.7

83.94

79.25

umol/l

62.33

30971

250087

(3014765) Yersinia sp identified in Stool by Organism specific culture

1707

6111

2.50

249.93

1.3

1.2

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

8357

50670

1.58

249.81

2.0

1.7

1.25

1.32

mg/l

1.24

6525

39385

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

7714

45929

1.60

249.06

3.4

3.1

2.46

mmol/l

0.38

6649

40131

(42529406) Shigella sp [Presence] in Stool by Culture

1706

6124

2.49

248.32

1.3

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

1688

6064

2.49

245.24

1.3

1.2

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

4577

23949

1.76

241.11

7.8

8.0

119.23

121.30

g/l

9.55

4488

23305

(3020779) Urea [Moles/volume] in Serum or Plasma

4317

22215

1.79

240.69

9.3

6.9

10.92

10.26

mmol/l

6.64

4093

21048

(3020682) Albumin/Creatinine [Ratio] in Urine

12148

80396

1.49

239.73

4.2

3.8

11.65

8.64

mg/mmol

8.11

8116

49881

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

28391

223697

1.70

239.30

19.7

14.3

75.79

77.76

ml/min/173m2

45.04

24227

185450

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

3731

18452

1.85

236.62

4.6

3.7

102.13

91.44

ng/l

8.36

3269

15674

(36660697) Celiac disease serology panel - Serum

3342

15989

1.91

234.85

1.2

—

(3018418) pH of Serum or Plasma

11323

74228

1.49

232.12

5.1

4.1

7.40

0.43

1565

14668

(3024354) Oxygen [Partial pressure] in Venous blood

3735

18592

1.84

231.70

3.9

3.0

4.54

4.56

kpa

0.12

3611

17974

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

29037

230790

1.73

228.35

5.7

4.8

6.13

6.01

mmol/l

43.27

26715

208776

(3026782) Osmolality of Urine

8077

49475

1.55

226.94

3.5

2.9

534.80

541.69

mosm/kgh2o

0.58

6788

42610

(3014007) Fractional oxyhemoglobin in Arterial blood

3281

15870

1.88

222.29

8.5

9.1

93.76

93.82

0.18

3273

15808

(3012516) Albumin [Mass/volume] in Urine

11506

76328

1.47

218.77

3.6

3.2

492.57

404.51

mg/l

1.08

7771

47978

(3003327) Ova and parasites identified in Stool by Light microscopy

1711

6523

2.35

217.64

1.8

1.7

—

(3009508) Creatinine [Moles/volume] in Urine

11763

78512

1.47

215.98

3.5

3.2

7.33

7.43

mmol/l

1.67

9937

65253

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

3250

15814

1.87

215.79

8.5

9.0

0.66

0.67

0.98

3236

15705

(3012095) Magnesium [Moles/volume] in Serum or Plasma

6786

40401

1.58

214.20

3.6

3.3

0.81

0.82

mmol/l

6.54

6339

37619

(3020630) Protein [Mass/volume] in Serum or Plasma

4039

21096

1.75

211.95

2.5

2.6

66.06

66.40

g/l

1.91

3652

19083

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

3242

15873

1.86

210.85

8.4

8.9

1.39

1.37

0.54

3225

15755

(3018677) aPTT in Platelet poor plasma by Coagulation assay

6498

38458

1.58

209.82

2.3

2.0

30.10

29.88

1.81

6319

37317

(3013512) EKG study

11114

73726

1.46

208.74

4.9

4.0

—

(3000850) Epithelial cells [#/volume] in Urine

8332

52175

1.52

208.23

2.9

2.6

4.60

5.15

e6/l

3.95

7374

46891

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

6763

40529

1.56

206.35

2.0

1.8

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

7851

48764

1.52

202.99

4.5

3.8

528.19

490.21

ng/l

0.12

6545

39532

(3009542) Hematocrit [Volume Fraction] of Blood

31465

257940

2.12

201.17

33.6

22.1

39.43

40.18

28.76

29548

239780

(3007461) Platelets [#/volume] in Blood

31476

258082

2.12

200.79

33.5

22.0

246.58

247.36

e9/l

1.23

30926

250499

(3035941) MCH [Entitic mass]

31476

258185

2.12

198.65

33.3

21.9

30.34

30.40

8.28

31170

253920

(3013139) Helicobacter pylori Ag [Presence] in Stool

3029

14782

1.86

198.40

1.3

1.2

—

(3024731) MCV [Entitic volume]

31478

258221

2.12

198.37

33.3

21.9

91.47

91.40

1.88

31172

253945

(3010813) Leukocytes [#/volume] in Blood

31479

258239

2.12

198.23

33.5

22.0

6.89

6.74

e9/l

20.97

30826

249759

(3026361) Erythrocytes [#/volume] in Blood

31478

258235

2.11

198.08

33.5

22.0

4.40

4.47

e12/l

103.47

30828

249731

(3000963) Hemoglobin [Mass/volume] in Blood

31480

258286

2.11

197.49

33.7

22.1

132.28

135.11

g/l

191.31

31176

254030

(3019150) Specific gravity of Urine by Refractometry

8027

50346

1.51

197.13

5.2

4.2

1.02

kg/l

0.51

1220

7709

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

29552

237867

1.71

194.96

6.0

5.2

2.60

2.72

mmol/l

87.96

27395

217434

(40761535) Cells panel - Urine sediment

3844

20290

1.73

193.06

4.2

3.4

—

(3004588) Protein electrophoresis panel - Serum or Plasma

3402

17459

1.77

188.27

2.3

2.4

—

(3007853) Bacteria identified in Skin by Aerobe culture

4950

28113

1.62

187.52

2.0

1.8

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2161

9617

2.02

185.58

1.1

—

(3037522) Nuclear Ab [Titer] in Serum

5197

30016

1.60

183.23

1.4

1.3

514.95

545.42

titre

0.56

1109

6440

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

27995

223161

1.57

180.71

4.7

4.1

1.36

1.30

mmol/l

28.41

25555

202001

(3044889) 12 lead EKG panel

22382

170950

1.42

178.15

4.7

3.9

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

2053

9138

2.01

175.94

1.4

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

2394

11249

1.91

175.33

5.0

4.0

24.00

24.17

mmol/l

1.83

2333

10971

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

28732

230802

1.60

174.46

5.2

4.6

1.43

1.46

mmol/l

39.17

26487

210724

(3025941) Bacteria identified in Stool by Culture

2535

12170

1.87

173.79

1.4

1.2

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

4060

22326

1.66

173.71

2.5

2.3

6.10

7.47

ug/l

4.86

3513

19359

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

28914

232801

1.60

171.35

5.3

4.6

4.49

4.63

mmol/l

93.49

26924

213773

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

2712

13373

1.83

170.63

8.7

9.1

24.23

24.35

mmol/l

1.15

2601

12901

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

5277

31091

1.56

169.36

9.8

7.2

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

4818

27833

1.59

168.28

1.9

1.7

—

(4200892) Spirometry reversibility

3318

17454

1.72

167.16

1.5

1.4

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

4779

27853

1.57

159.91

2.0

1.8

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

1757

7695

2.04

157.01

1.7

1.6

—

(3020961) Endomysium IgA Ab [Titer] in Serum

1947

8892

1.96

154.52

1.1

193.89

215.26

titre

0.12

233

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

12616

88937

1.37

153.84

5.5

5.0

3.06

3.52

ug/l

0.79

11362

79521

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1911

8710

1.96

152.50

3.1

2.9

0.32

0.35

u/ml

3.59

1087

5008

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

2849

14776

1.74

150.15

1.8

1.7

—

(3005719) IgG [Mass/volume] in Serum or Plasma

3162

16926

1.69

148.40

2.7

2.8

10.56

10.64

g/l

0.40

2928

15425

(3028026) IgM [Mass/volume] in Serum or Plasma

2597

13172

1.77

147.84

1.9

1.40

1.33

g/l

0.65

2376

11903

(3000494) Fungus identified in Specimen by Culture

4694

27731

1.55

146.72

1.6

1.4

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2050

9705

1.89

145.88

2.3

3.71

3.75

g/l

0.41

1816

8674

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2053

9727

1.89

145.73

2.2

2.3

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2054

9740

1.89

145.41

2.3

7.44

7.43

g/l

0.07

1817

8701

(3019060) Gas panel - Arterial blood

3167

17050

1.68

145.29

4.7

4.9

—

(3002385) Erythrocyte distribution width [Ratio]

25322

200163

1.41

144.69

26.1

17.7

16.06

15.16

6.61

25056

196441

(3021589) Normoblasts [#/volume] in Blood

14436

104597

1.35

144.57

11.7

9.9

0.00

e9/l

1.58

11799

85769

(3004119) Hemoglobin [Mass/volume] in Venous blood

2857

15081

1.71

140.86

4.2

3.2

125.26

128.78

g/l

12.71

2794

14747

(3002256) Pathology report gross observation

5186

31574

1.50

140.22

1.3

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

3703

20976

1.60

138.29

1.7

1.5

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

2303

11569

1.78

135.00

3.3

2.7

1.25

1.24

0.37

2295

11508

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

17043

127445

1.33

133.47

2.7

2.5

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

2255

11319

1.78

132.45

3.3

2.7

0.66

0.65

0.18

2250

11274

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1907

9096

1.87

132.23

2.2

2.3

10.22

10.21

g/l

0.04

1658

8000

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

2602

13704

1.70

128.83

9.5

9.6

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1901

9137

1.85

128.59

2.3

2.4

3.00

2.94

g/l

1.49

1667

8101

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1570

7085

1.97

128.45

1.3

—

(3034770) Mitochondria Ab [Titer] in Serum

1365

5930

2.04

124.18

1.3

1.2

833.33

973.23

titre

0.36

192

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1741

8239

1.88

123.51

2.4

2.5

0.92

0.99

g/l

0.34

1480

6979

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

1935

9476

1.82

123.11

4.6

3.8

24.71

24.94

mmol/l

2.74

1784

8696

(3022313) Gas panel - Capillary blood

2183

11095

1.76

122.54

4.3

3.6

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

3901

22979

1.54

121.63

1.7

1.5

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

2088

10509

1.77

121.18

1.5

14.04

15.90

u/ml

0.24

278

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1319

5709

2.05

121.17

1.6

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

3525

20402

1.56

118.77

2.3

364.26

375.69

nmol/l

2.76

3239

18744

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

2856

15743

1.63

118.20

4.2

3.5

5.14

5.16

kpa

0.71

2695

14845

(3007566) Smooth muscle Ab [Titer] in Serum

1352

5971

2.01

117.43

1.3

1.2

104.54

133.27

titre

0.76

108

520

(3009343) pH of Capillary blood

2820

15540

1.63

116.78

4.2

3.5

7.41

7.42

3.34

268

2159

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

2738

14990

1.64

116.36

4.2

3.4

1.50

1.88

mmol/l

5.56

2057

11177

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

1600

7522

1.89

115.68

2.3

37.30

37.49

g/l

0.59

1361

6466

(3019225) pH of Specimen

4152

25056

1.50

115.02

5.1

4.2

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

828

3045

2.40

113.37

2.7

2.4

159.98

1044.81

u/ml

1.63

819

3005

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

2171

11255

1.72

113.32

5.1

3.9

48.33

47.71

0.56

2160

11130

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

2629

14362

1.64

112.53

1.6

1.5

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

1537

7196

1.90

112.48

2.4

2.3

0.03

g/l

0.08

1385

6548

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

3384

19726

1.54

109.90

2.8

2.7

61.49

63.34

ml/min/173m2

1.95

1483

7876

(3008152) Bicarbonate [Moles/volume] in Arterial blood

2866

16088

1.60

109.68

7.3

7.2

24.58

24.64

mmol/l

0.38

2766

15317

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

1439

6687

1.91

107.65

2.4

0.00

g/l

0.66

1289

6064

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

1418

6584

1.91

106.32

2.4

0.00

g/l

-0.00

1288

6041

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

5915

38670

1.40

105.98

1.3

29.96

40.80

iu/ml

5.38

1844

12488

(3037121) Protein [Mass/volume] in Urine

1671

8186

1.81

105.81

3.1

0.33

0.32

g/l

0.28

747

3475

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1417

6608

1.90

104.84

1.5

13.33

16.42

iu/ml

0.35

164

(46235355) HIV 1 and 2 tests - Meaningful Use set

4292

26566

1.46

103.81

1.8

1.6

—

(3020891) Body temperature

1949

10053

1.73

103.32

5.3

4.9

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1162

5089

2.02

103.16

1.4

—

(3003338) MCHC [Mass/volume]

24133

192555

1.32

102.81

29.7

19.5

330.91

332.10

g/l

73.70

23975

191022

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

12202

89218

1.30

101.83

5.1

4.0

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1668

8261

1.79

101.78

2.9

3.4

45.93

43.60

mg/l

0.13

1441

6607

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

1675

8322

1.79

101.11

1.1

3.19

8.63

u/ml

0.69

128

(3027273) Bicarbonate [Moles/volume] in Venous blood

2268

12250

1.65

101.10

4.4

3.4

25.09

25.29

mmol/l

1.96

2221

11901

(3034860) Kappa light chains.free [Mass/volume] in Serum

1667

8278

1.79

100.79

2.9

3.4

88.99

65.38

mg/l

0.37

1441

6616

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

9955

70911

1.31

100.66

4.8

4.3

21.85

22.02

0.51

5213

35430

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

4814

30640

1.43

99.87

5.0

4.7

32.74

32.50

0.76

3479

20581

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

5563

36344

1.39

99.27

1.3

13.69

13.51

u/ml

0.04

1909

13599

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1620

8036

1.79

98.25

2.9

3.4

2.92

4.91

ratio

0.70

652

(4035726) Immunohistochemistry procedure

3659

22169

1.49

98.22

1.4

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

3657

22160

1.49

98.09

3.1

2.9

237.90

215.60

ng/l

1.84

3335

20312

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

1629

8128

1.78

96.84

1.6

195.00

266.16

titre

0.64

383

(3018405) Lactate [Moles/volume] in Arterial blood

1750

8929

1.74

96.26

4.3

4.2

1.37

1.39

mmol/l

0.26

1722

8767

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1719

8803

1.73

93.27

2.4

2.3

427.14

578.09

ug/l

1.31

1618

8309

(3000492) Spirometry study

3486

21307

1.47

88.92

1.6

1.5

—

(3043409) Potassium [Moles/volume] in Arterial blood

1528

7686

1.76

88.19

4.4

4.5

3.86

3.89

mmol/l

2.18

1516

7619

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

3824

23944

1.44

85.66

1.9

1.7

1.60

1.50

10.17

3220

20660

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1695

8852

1.70

85.49

2.8

2.7

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

7602

53233

1.31

83.82

1.8

1.7

35341609.84

32165488.91

pmol/l

0.18

6375

43283

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

1132

5299

1.88

82.56

3.1

3.3

173.85

993.07

u/ml

5.17

1016

4824

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2550

14992

1.52

78.22

7.8

6.8

24.79

24.82

mmol/l

0.16

2528

14848

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

320

884

3.16

75.77

1.1

1.0

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

722

2975

2.13

75.34

1.5

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

721

2971

2.13

75.22

1.5

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

719

2971

2.12

74.48

1.5

1.4

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

810

3504

2.03

74.28

1.7

1.5

0.70

0.81

g/l

2.07

631

2598

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

1288

6479

1.75

74.15

1.5

1.6

15.44

6.49

iu/ml

0.35

296

1457

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

723

3003

2.11

73.90

1.5

1.4

—

(3052851) Hemolysis interference index of Serum or Plasma

1434

7448

1.70

73.61

3.8

3.2

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

722

3013

2.10

72.90

1.5

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

734

3087

2.09

72.61

1.5

1.4

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

7202

50873

1.29

72.55

3.3

3.0

0.76

0.79

ug/l

0.92

5309

34501

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

1119

5435

1.81

72.51

1.4

1.3

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1867

10470

1.58

70.61

2.1

2.0

2.04

2.21

ug/l

0.30

1655

9200

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

1084

5266

1.81

70.18

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

1084

5267

1.81

70.14

1.4

1.3

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

478

1705

2.45

70.00

1.3

1.2

—

(3049717) Cytology report of Urine Cyto stain

1835

10382

1.57

66.70

2.9

2.7

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

1078

5318

1.79

66.29

1.1

6.37

7.83

u/ml

0.32

558

(3029937) Albumin [Presence] in Urine by Test strip

8724

63668

1.26

66.13

5.3

4.2

0.00

estimate

0.46

2239

21278

(3037756) Immunofixation for Serum or Plasma

1109

5529

1.77

65.78

1.5

1.7

—

(40760888) Immunoglobulin light chains.free panel - Serum

1218

6261

1.71

64.85

2.8

3.5

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

1269

6611

1.69

64.32

2.6

2.4

3.70

3.63

g/l

0.85

1217

6298

(3017732) Neutrophils [#/volume] in Blood

2596

15925

1.45

63.83

3.0

6.11

4.98

e9/l

1.97

1966

12437

(3007930) Methemoglobin/Hemoglobin.total in Blood

1831

10457

1.55

63.78

5.4

5.1

0.88

0.89

0.45

1745

9809

(3023183) Ammonium ion [Moles/volume] in Plasma

1044

5187

1.77

62.65

3.6

2.5

34.58

33.60

umol/l

0.62

928

4640

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

654

2785

2.06

62.61

3.5

3.3

7.66

8.41

nmol/l

0.12

637

2707

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1850

10649

1.54

62.15

5.3

5.0

1.69

1.65

0.87

1764

9996

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

680

2948

2.02

62.00

1.1

1.55

1.53

g/l

0.76

608

2666

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

4449

30093

1.33

60.22

1.4

—

(3024928) Oxygen saturation in Venous blood

1025

5135

1.76

59.77

3.5

3.0

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

1236

6563

1.66

58.22

1.6

0.24

g/l

0.09

1174

6194

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

1266

6771

1.65

57.98

1.6

1.18

g/l

0.05

1206

6417

(3021879) Hepatitis B virus core Ab [Presence] in Serum

2251

13690

1.46

57.70

1.4

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

373

1298

2.51

57.65

1.3

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

370

1288

2.51

57.15

1.3

1.2

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

1697

9768

1.54

56.91

2.0

1.9

39.58

39.09

u/l

0.44

1463

8502

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

2453

15210

1.43

56.66

2.5

2.4

25.22

25.50

au/ml

0.03

132

1058

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

2256

13775

1.45

56.60

1.3

49.80

56.09

au/ml

0.65

117

752

(3036489) Thrombin time

1496

8403

1.57

55.94

2.1

1.9

22.21

21.71

1.28

1348

7404

(3027456) Digoxin [Moles/volume] in Serum or Plasma

1014

5176

1.72

55.32

3.4

3.1

0.78

0.81

nmol/l

1.60

795

4009

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

1248

6743

1.63

54.87

2.2

2.1

90.95

90.34

0.41

1203

6457

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

959

4834

1.74

54.72

1.6

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

1160

6163

1.66

54.50

2.4

200.78

198.23

0.43

1097

5816

(3003694) ABO and Rh group [Type] in Blood

8169

60280

1.23

53.69

1.3

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

700

3227

1.90

53.46

1.3

1.2

—

(3005322) IgE [Units/volume] in Serum or Plasma

2106

12852

1.45

52.88

1.3

219.72

242.26

u/ml

0.37

1926

11877

(3030981) Hyaline casts [#/volume] in Urine by Automated count

2162

13259

1.44

52.88

3.1

2.8

0.28

0.29

e6/l

0.20

2112

12937

(21494890) Protein electrophoresis panel - 24 hour Urine

607

2694

1.97

51.86

1.8

2.1

—

(3044927) Protein electrophoresis panel - Urine

582

2557

1.99

51.18

1.2

—

(3045414) Leukocytes [Presence] in Urine

1791

10675

1.48

50.72

2.0

1.9

—

(3038515) Glucose [Moles/volume] in Venous blood

1015

5348

1.67

49.22

4.5

3.3

7.65

7.62

mmol/l

0.10

996

5253

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

916

4696

1.71

49.20

6.4

5.5

853.93

1271.61

iu/ml

0.42

163

726

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

764

3725

1.80

48.86

1.2

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

731

3518

1.82

48.80

1.4

—

(3008037) Lactate [Moles/volume] in Venous blood

1055

5651

1.64

47.98

4.4

3.2

1.58

1.61

mmol/l

0.48

1037

5536

(1761482) Bacteria [#/volume] in Urine by Culture

1206

6678

1.59

47.88

5.1

4.2

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

787

3900

1.77

47.65

1.3

1.2

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

432

1747

2.16

47.41

1.2

127.14

153.85

titre

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

432

1752

2.16

47.07

1.2

210.16

162.38

titre

0.48

311

(40768443) Skin Pathology biopsy report

1796

10878

1.46

46.78

1.2

—

(3000330) Specific gravity of Urine by Test strip

2027

12610

1.42

45.66

4.5

3.5

—

(4062490) Immunoglobulin typing, IgG

503

2226

1.98

43.40

1.4

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

503

2229

1.97

43.23

1.4

0.42

g/l

0.03

377

1522

(3015171) Extractable nuclear Ab [Units/volume] in Serum

1468

8677

1.49

43.23

1.2

0.77

0.88

u/ml

0.16

148

797

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

521

2338

1.95

43.18

3.4

2.7

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

503

2230

1.97

43.18

1.4

2.80

2.99

g/l

1.51

374

1520

(3027135) IgG subclass 1 [Mass/volume] in Serum

503

2232

1.97

43.07

1.4

6.79

6.89

g/l

0.22

374

1520

(3000475) Leukocytes [#/volume] in Synovial fluid

1106

6156

1.58

42.93

1.7

1.6

16844.52

13711.12

e6/l

1.09

810

4477

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

2137

13581

1.39

42.47

3.0

3.3

4.35

4.42

pmol/l

2.19

1855

11996

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

913

4873

1.64

42.12

1.3

1.2

187.06

132.69

titre

0.28

104

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1708

10464

1.44

41.78

2.1

2.0

—

(3045424) Erythrocytes [Presence] in Urine

773

3958

1.71

41.73

1.5

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

247

838

2.57

40.40

1.2

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

533

2472

1.89

40.06

3.9

3.6

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1574

9609

1.44

39.21

1.9

1.8

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

741

3825

1.70

38.85

1.2

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

640

3176

1.76

38.62

3.0

2.4

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

2587

17187

1.33

38.57

2.4

2.1

11.88

12.53

nmol/l

3.23

2244

15225

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1179

6861

1.51

37.41

1.5

1.4

—

(40757494) Bilirubin.total [Moles/volume] in Blood

328

1315

2.18

36.91

2.3

2.1

17.01

26.80

umol/l

1.19

122

(3000093) Morphology [Interpretation] in Blood Narrative

502

2359

1.86

36.27

1.2

1.1

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

693

3580

1.69

36.25

1.3

1.2

304.81

279.44

u/ml

1.21

461

2251

(3048929) Epstein Barr virus Ab [Presence] in Serum

921

5111

1.58

36.23

1.2

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

673

3457

1.70

35.96

7.2

6.0

12.11

11.82

mg/l

0.95

610

3170

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

1088

6282

1.52

35.83

2.4

2.2

125.06

112.42

ug/min

0.41

640

3640

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

364

1541

2.06

35.60

1.7

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

522

2517

1.81

34.74

1.7

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

960

5433

1.55

34.66

1.2

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

375

1623

2.02

34.55

1.4

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

1059

6129

1.52

34.49

1.3

1.2

25.18

41.44

u/ml

1.49

363

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

369

1593

2.02

34.24

1.4

—

(3026250) Tacrolimus [Mass/volume] in Blood

248

913

2.37

34.17

36.5

33.2

7.06

7.28

ug/l

0.94

221

813

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

668

3480

1.68

33.89

1.1

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

296

1188

2.17

33.27

1.5

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

296

1188

2.17

33.27

1.5

1.4

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

491

2356

1.82

33.23

1.7

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

769

4178

1.61

33.08

1.6

1.4

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

637

3305

1.69

32.83

1.4

1.3

1.96

1.55

nmol/l

0.11

606

3180

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

619

3195

1.69

32.53

2.6

2.0

25.41

27.56

mg/l

0.40

152

865

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

1145

6815

1.47

32.53

1.6

1.7

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

847

4728

1.57

32.51

1.2

4.32

5.27

u/ml

0.15

374

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

984

5679

1.52

32.48

1.3

9.20

6.71

u/ml

0.52

144

931

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1046

6116

1.50

32.45

3.4

2.8

1.80

1.61

mg/l

8.59

966

5525

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

973

5605

1.52

32.40

1.3

5.16

6.16

u/ml

0.21

602

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

761

4148

1.61

32.31

1.6

1.4

26.83

18.20

u/ml

1.03

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

991

5748

1.51

31.96

1.6

1.5

—

(21494434) Karyotype in Bone marrow

453

2157

1.83

31.46

1.2

1.1

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

632

3316

1.67

31.24

1.4

1.3

0.18

0.25

nmol/l

0.93

259

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

531

2660

1.74

31.10

1.2

58.67

62.37

u/l

0.55

479

2365

(1761868) Lipid panel - Serum or Plasma

8096

78991

0.85

31.07

3.4

3.0

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

3319

23412

1.26

30.85

1.6

1.5

—

(3003434) Protein [Mass/volume] in Pleural fluid

673

3610

1.63

30.52

1.5

1.4

31.02

32.98

g/l

3.63

584

3266

(3023199) Leukocytes [#/volume] in Pleural fluid

614

3218

1.67

30.49

1.5

1871.63

3301.93

e6/l

2.25

431

2364

(3042733) HLA Ab [Presence] in Serum

200

706

2.47

30.27

5.6

4.9

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

692

3751

1.61

30.09

1.6

1.4

113.51

116.66

u/ml

0.32

156

866

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

283

1162

2.12

30.09

1.4

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

283

1163

2.12

30.02

1.4

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

495

2466

1.75

29.59

1.1

4.04

3.58

u/ml

0.17

157

1060

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

580

3027

1.67

29.29

1.4

1.3

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

836

4765

1.54

29.27

1.2

8.21

12.80

u/ml

0.28

(3042111) Morphology [Interpretation] in Bone marrow Narrative

753

4195

1.57

29.18

1.5

1.6

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

663

3586

1.62

29.10

3.0

2.6

1105.67

5594.20

u/ml

1.00

225

(3003181) Sodium [Moles/volume] in Urine

795

4488

1.55

29.07

1.4

1.3

60.37

62.29

mmol/l

0.71

631

3570

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

1045

6257

1.46

28.81

2.1

2.0

12.42

11.20

mg/l

5.04

969

5779

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

706

3904

1.58

28.27

1.7

1.6

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

706

3904

1.58

28.27

1.7

1.6

—

(3005570) Glucose [Moles/volume] in Urine

479

2401

1.74

28.05

1.8

1.9

—

4.10

—

(40768441) Liver Pathology biopsy report

361

1660

1.90

28.02

1.6

1.3

—

(3023419) Bacteria identified in Sputum by Culture

708

3928

1.58

27.95

2.6

2.4

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

326

1456

1.95

27.60

1.2

30.72

24.54

u/l

0.88

275

1240

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

332

1499

1.93

27.23

1.2

98.72

90.12

u/l

0.68

285

1308

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

237

953

2.17

26.64

3.0

2.8

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

547

2889

1.65

26.44

1.4

1.3

—

nmol/l

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

552

2928

1.65

26.24

1.5

1.4

64994.90

56633.11

e6/l

0.24

326

1774

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

561

2988

1.64

26.24

1.3

1.2

3.83

3.94

u/ml

0.08

261

1327

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

8291

64472

1.15

26.06

1.7

1.41

1.36

mmol/l

4.85

7156

53166

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

496

2563

1.69

26.06

1.6

1.5

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

496

2564

1.69

26.02

1.6

1.5

—

(3051611) Lipemic interference index of Serum or Plasma

511

2667

1.67

25.86

3.7

3.3

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

766

4405

1.52

25.78

1.4

1.3

11.76

11.33

u/l

0.33

623

3560

(21494755) Public health laboratory ask at order entry panel

1411

16297

0.74

25.58

1.4

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

270

1160

2.03

25.54

2.2

2.4

1028.69

1239.21

u/ml

0.75

261

1146

(3016650) Hepatitis A virus Ab [Presence] in Serum

620

3412

1.59

25.38

1.1

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

704

4014

1.53

24.67

1.3

36.80

36.56

u/l

0.02

610

3480

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

341

1611

1.85

24.41

1.0

292.79

473.29

mg/l

0.49

293

1444

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

722

4157

1.52

24.19

1.9

185.56

197.50

pmol/l

2.58

662

3912

(3051651) Icteric interference index of Serum or Plasma

316

1462

1.88

24.15

4.2

3.9

—

(3021788) Differential panel - Synovial fluid

792

4661

1.49

23.88

1.5

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1187

7527

1.38

23.78

1.8

1.7

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

752

4394

1.50

23.49

1.2

36.37

45.53

u/ml

0.79

458

(3010375) cycloSPORINE [Mass/volume] in Blood

240

1022

2.05

23.32

31.5

28.6

114.42

113.97

ug/l

0.04

199

865

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

424

2168

1.71

23.22

1.7

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

424

2168

1.71

23.22

1.7

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

424

2168

1.71

23.22

1.7

1.6

—

(3017704) Immunofixation for Urine

305

1414

1.88

23.19

1.4

1.7

—

(3039000) Anion gap in Blood

936

5733

1.43

22.92

6.9

11.15

11.20

mmol/l

0.15

859

5176

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

937

5741

1.43

22.91

1.8

1.7

42.20

43.06

nmol/l

0.54

902

5558

(3018572) Chloride [Moles/volume] in Blood

936

5734

1.43

22.90

6.9

105.14

105.02

mmol/l

0.32

859

5177

(3003129) Base excess in Capillary blood by calculation

167

620

2.34

22.78

2.0

1.7

0.27

0.68

mmol/l

0.57

156

587

(3036603) Volume of Urine

338

1632

1.81

22.60

1.6

1.5

1934.07

1899.41

0.30

326

1580

(3010144) Erythrocytes [#/volume] in Synovial fluid

456

2397

1.66

22.53

1.4

190132.13

114466.25

e6/l

1.15

323

1646

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

561

3114

1.57

22.20

1.3

1.2

3.22

4.08

u/ml

0.64

194

1093

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

929

5716

1.42

22.20

1.7

1.6

—

(3004616) Nuclear Ab [Presence] in Serum

516

2810

1.60

22.14

1.3

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

790

4726

1.46

21.96

1.8

1.7

0.88

0.83

nmol/l

1.01

660

3917

(3006270) Folate [Moles/volume] in Blood

399

2040

1.71

21.89

1.3

1.2

323.36

353.82

nmol/l

2.17

312

1678

(3017181) Myelocytes/100 leukocytes in Blood

2922

21065

1.22

21.87

4.3

4.0

1.00

0.97

0.23

1141

7440

(3039162) Centromere protein B Ab [Units/volume] in Serum

510

2779

1.60

21.84

1.2

53.52

57.56

u/ml

0.13

185

(4146454) Self-monitoring of blood glucose

526

2891

1.59

21.73

2.8

2.7

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

678

3949

1.50

21.55

1.4

1.5

—

(3020876) Protein [Mass/time] in 24 hour Urine

519

2852

1.59

21.46

2.3

2.5

1.21

1.22

g/24h

0.01

239

1422

(3023487) Leukocytes [#/volume] in Peritoneal fluid

213

897

2.07

21.37

2.5

1.8

3328.52

3927.58

e6/l

0.08

159

599

(3044941) Cell count panel - Synovial fluid

676

3945

1.50

21.29

1.5

1.4

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

370

1876

1.72

20.95

1.4

13.43

12.89

u/l

0.85

360

1802

(3012441) Differential panel - Pleural fluid

506

2783

1.59

20.86

1.5

—

(3047181) Lactate [Moles/volume] in Blood

1242

8100

1.34

20.83

6.3

5.9

1.26

1.33

mmol/l

1.94

1106

7180

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

950

5941

1.40

20.71

1.6

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

854

5252

1.42

20.49

1.5

—

(3024471) HLA-A [Type]

180

723

2.17

20.43

1.0

—

(3024932) HLA-DR beta [Type]

177

707

2.18

20.37

1.1

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

456

2464

1.61

20.25

1.4

1.3

493.03

471.57

u/l

0.05

429

2335

(3015235) Bicarbonate [Moles/volume] in Capillary blood

1031

6565

1.37

20.17

3.2

3.0

24.43

24.88

mmol/l

2.93

1009

6422

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

734

4403

1.46

20.15

1.5

1.4

—

(3023420) DNA double strand Ab [Units/volume] in Serum

429

2287

1.64

20.12

1.4

1.5

19.36

29.68

iu/ml

1.60

105

(40768806) Pleura Pathology biopsy report

506

2814

1.57

19.92

1.5

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

241

1089

1.93

19.89

2.4

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

862

5339

1.41

19.88

1.1

—

(3033799) Differential panel - Peritoneal fluid

187

771

2.11

19.88

2.0

1.9

—

(3045788) Cell count panel - Pleural fluid

456

2481

1.60

19.70

1.5

—

(3036782) Glucose [Moles/volume] in Pleural fluid

450

2447

1.60

19.49

1.4

1.3

6.85

6.29

mmol/l

3.18

412

2269

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

902

5663

1.39

19.24

1.4

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

302

1482

1.78

19.22

1.1

—

(3026389) Candida sp identified in Specimen by Organism specific culture

578

3338

1.51

19.19

1.4

1.3

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

349

1788

1.70

19.08

1.1

—

(3032057) Clostridioides difficile [Presence] in Stool

139

516

2.34

19.06

2.0

1.7

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

303

1497

1.76

18.85

1.4

13.49

13.19

umol/l

0.27

284

1419

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

1657

11397

1.28

18.81

3.0

3.8

44.95

64.17

u/ml

2.52

1593

10987

(3035947) Staphylolysin Ab [Units/volume] in Serum

250

1168

1.86

18.68

1.2

1.1

2.92

4.49

iu/ml

1.39

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

134

497

2.35

18.43

1.2

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

580

3384

1.50

18.36

1.2

1.1

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

282

1377

1.78

18.28

2.3

2.5

0.23

0.24

e9/l

0.06

248

1226

(3006462) Nitrate [Presence] in Urine

240

1123

1.86

17.87

4.6

3.1

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

155

621

2.17

17.78

1.7

1.3

13.22

13.45

g/l

0.11

124

471

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

290

1442

1.75

17.68

2.3

2.5

500.86

531.46

e6/l

0.28

247

1235

(3043410) Blood group antigens tested for on Red Blood Cells

156

631

2.15

17.48

1.7

1.9

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

367

1952

1.64

17.45

1.3

11.90

13.78

u/l

0.89

344

1796

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

277

1365

1.77

17.43

1.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

355

1873

1.65

17.42

1.2

—

(3011985) Renin [Units/volume] in Plasma

548

3197

1.50

17.38

1.4

71.16

58.50

mu/l

0.61

486

2828

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

277

1370

1.76

17.22

1.1

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

184

798

2.01

17.16

2.3

1.7

5689.05

12193.42

e6/l

0.98

114

422

(3010838) Calcium [Moles/time] in 24 hour Urine

711

4380

1.42

16.98

1.9

1.8

4.91

5.04

mmol/24h

0.50

625

3816

(3013005) Retinol [Moles/volume] in Serum or Plasma

176

755

2.03

16.93

1.8

1.5

2.02

umol/l

0.00

168

702

(3021440) Promyelocytes/100 leukocytes in Blood

2729

20037

1.20

16.76

4.4

4.1

0.12

0.11

0.30

958

6450

(3035637) Corticotropin [Mass/volume] in Plasma

483

2769

1.52

16.67

1.5

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

310

1603

1.69

16.46

1.2

1.1

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

257

1261

1.78

16.45

1.2

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

240

1154

1.81

16.43

2.5

1.9

91.70

98.05

1.76

227

1087

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

359

1929

1.62

16.42

2.3

2.4

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

311

1612

1.68

16.37

1.2

1.1

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

706

4374

1.41

16.34

1.7

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

309

1601

1.68

16.29

1.2

1.1

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

304

1570

1.69

16.23

1.6

1.5

6.40

7.06

u/l

0.33

245

1255

(3019420) Tryptase [Mass/volume] in Serum or Plasma

225

1065

1.84

16.21

1.5

10.67

8.44

ug/l

0.54

212

967

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

310

1610

1.68

16.20

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

309

1604

1.68

16.18

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

310

1611

1.68

16.17

1.2

1.1

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

368

2002

1.60

16.02

2.3

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1654

11599

1.25

15.94

1.8

1.7

—

(3025159) Blasts/100 leukocytes in Blood

2574

18885

1.20

15.91

4.4

4.1

0.19

0.35

0.74

818

5368

(3047189) Immunofixation for 24 hour Urine

245

1199

1.78

15.84

1.6

1.8

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

566

3388

1.46

15.82

1.7

1.9

23.91

25.14

ug/l

0.14

554

3315

(40768446) Kidney Pathology biopsy report

189

853

1.93

15.78

1.8

1.6

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

415

2332

1.55

15.73

1.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

213

2.94

15.58

1.6

53.63

43.93

umol/l

1.24

213

(3045142) Bone marrow Pathology biopsy report

482

2809

1.50

15.43

1.3

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

505

2976

1.48

15.31

1.3

291.77

328.47

pmol/l

0.47

449

2545

(3002179) Metamyelocytes/100 leukocytes in Blood

2601

19169

1.19

15.29

4.0

3.9

0.69

0.70

0.05

995

6386

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1489

10382

1.26

15.10

1.8

1.7

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

141

583

2.10

15.02

1.2

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

217

1049

1.80

14.66

1.0

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

170

760

1.95

14.63

1.2

—

(3008898) HLA-B27 [Presence]

896

5877

1.33

14.56

1.1

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

131

534

2.13

14.49

2.8

2.3

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

507

3026

1.46

14.44

1.1

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

620

3840

1.41

14.43

1.4

—

(3020491) Glucose [Moles/volume] in Blood

311

1670

1.62

14.34

1.7

1.9

7.30

7.15

mmol/l

0.35

201

1169

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

136

565

2.09

14.34

1.2

316.72

285.30

pmol/l

0.24

100

406

(3017315) Amylase [Enzymatic activity/volume] in Urine

256

1309

1.70

14.25

1.2

338.45

315.53

u/l

0.07

230

1227

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

245

1238

1.72

14.23

2.2

97.25

112.39

ug/min

0.14

269

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

388

2200

1.54

14.18

1.2

1.1

95.22

95.64

0.11

363

2042

(3002331) Protein [Mass/volume] in Peritoneal fluid

135

562

2.09

14.16

1.4

25.69

39.16

g/l

0.68

102

437

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

578

3549

1.42

14.14

1.5

1.4

—

(4094501) Cardiovascular stress test using bicycle ergometer

1022

6860

1.30

14.09

1.1

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

175

801

1.90

14.07

1.5

1.7

16353.72

32316.51

u/ml

0.37

113

(3014148) Varicella zoster virus Ab [Titer] in Serum

381

2157

1.54

14.03

1.1

—

(3004775) Volume in Urine collected for unspecified duration

374

2114

1.54

13.87

2.5

2.2

727.17

675.62

1.34

255

1401

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

378

2151

1.53

13.61

1.4

1.3

1.53

1.42

nmol/l

1.07

347

1935

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

297

1600

1.62

13.55

2.3

2.5

647.58

655.25

e6/l

0.05

285

1530

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

181

852

1.85

13.38

1.8

1.5

28.17

29.82

umol/l

1.14

174

817

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

458

2723

1.47

13.35

2.1

2.0

1153.22

3593.11

u/l

3.64

135

983

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

254

1323

1.67

13.24

1.5

1.4

5.98

5.92

u/l

0.03

207

1116

(3014051) Protein [Presence] in Urine by Test strip

953

6394

1.30

13.21

3.2

2.5

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

409

2383

1.50

13.19

1.4

1.3

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

473

2837

1.45

13.18

3.8

—

(3051593) INR in Capillary blood by Coagulation assay

249

1295

1.67

13.06

10.4

10.3

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

195

947

1.79

13.04

2.8

2.4

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

484

2924

1.44

12.99

1.2

1.1

120.44

117.67

1.02

448

2613

(3004809) Band form neutrophils/100 leukocytes in Blood

667

4259

1.37

12.98

3.3

3.4

1.56

1.55

0.03

591

3758

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

129

547

2.05

12.94

3.1

3.0

6.85

7.65

mg/l

0.70

114

433

(3022621) pH of Urine by Test strip

2179

16051

1.19

12.86

3.6

3.0

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

273

1461

1.63

12.82

3.0

1.8

17.93

16.18

nmol/l

2.93

261

1358

(3018133) Calcium [Moles/volume] in Urine

270

2.51

12.61

1.4

1.6

2.54

2.69

mmol/l

0.26

234

(1002224) Polysomnography panel

1179

8180

1.26

12.53

1.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

605

3831

1.38

12.43

1.1

1.2

—

(44813793) Dust mix specific IgE antibody measurement

265

1425

1.62

12.24

1.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1809

13172

1.20

12.13

1.2

114.54

139.85

iu/ml

2.35

644

4858

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

225

1168

1.68

11.94

1.2

—

(3001186) Copper [Moles/volume] in Serum or Plasma

113

471

2.09

11.90

1.2

17.21

16.68

umol/l

0.69

105

417

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

407

2421

1.46

11.89

1.1

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

376

2202

1.49

11.88

1.5

1.3

33.60

34.19

u/l

0.11

300

1790

(3017354) Segmented neutrophils/100 leukocytes in Blood

436

2635

1.44

11.73

3.2

3.4

58.47

57.27

0.55

374

2198

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

139

630

1.92

11.61

1.5

1.4

19.04

22.75

0.97

114

529

(3023383) Lactate [Moles/volume] in Pleural fluid

169

816

1.80

11.59

1.4

1.3

3.40

3.57

mmol/l

0.23

157

748

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

788

5250

1.31

11.56

1.7

4.93

13.83

iu/l

1.05

219

1810

(3011412) CD3 cells [#/volume] in Blood

367

2154

1.48

11.49

2.3

1.11

1.15

e9/l

0.30

329

1978

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

3.89

11.39

1.1

1.0

26.43

22.86

u/ml

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

3.89

11.39

1.1

1.0

35.80

32.26

u/ml

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

988

10742

0.79

11.28

1.5

—

(37021550) Renin [Units/volume] in Plasma --upright

115

494

2.02

11.21

1.2

1.3

84.50

61.19

mu/l

0.54

356

(3006184) Hemoglobin [Mass/volume] in Capillary blood

880

5979

1.29

11.15

2.4

2.2

125.64

129.25

g/l

3.52

592

4353

(3016244) Insulin [Units/volume] in Serum or Plasma

191

968

1.72

11.11

2.6

3.1

28.07

25.56

mu/l

0.35

182

900

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

370

2192

1.47

11.08

1.1

1.2

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

191

975

1.70

10.84

1.6

1.4

22.96

25.56

umol/l

0.58

185

915

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

320

1850

1.51

10.82

1.2

70.46

80.81

u/ml

0.23

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

307

1761

1.52

10.77

1.2

2.38

8.87

u/ml

1.96

111

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

344

2021

1.48

10.76

1.7

1.9

3.78

4.04

mg/l

0.59

326

1926

(3021387) Prolactin [Units/volume] in Serum or Plasma

683

4510

1.32

10.72

1.8

280.98

306.86

mu/l

1.10

631

4131

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

326

1897

1.50

10.69

1.8

1.6

—

(3044007) Cell count panel - Peritoneal fluid

151

723

1.82

10.68

2.3

1.8

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

320

1856

1.50

10.66

1.2

38.18

45.02

u/ml

0.22

141

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

129

590

1.90

10.54

7.9

5.7

65.24

71.05

1.57

481

(3016038) Potassium [Moles/volume] in Urine

289

1646

1.53

10.50

1.2

1.1

32.75

34.62

mmol/l

0.65

249

1387

(3022493) Free Hemoglobin [Mass/volume] in Plasma

196

1017

1.68

10.49

7.5

4.3

1769.70

1542.36

mg/l

0.06

152

709

(3038026) Centromere Ab [Units/volume] in Serum

326

1907

1.49

10.43

1.2

64.83

56.27

u/ml

0.13

(3036670) Protein [Mass/volume] in Synovial fluid

161

792

1.77

10.43

1.2

1.3

38.90

40.45

g/l

0.69

417

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

133

617

1.87

10.41

4.5

1.8

1.33

1.02

ug/l

0.49

128

581

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

283

1608

1.53

10.40

1.3

53.68

70.71

titre

0.44

140

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

535

3424

1.36

10.37

1.4

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

331

1947

1.48

10.31

1.5

1.6

21.43

25.87

u/ml

1.28

404

(3014271) Vancomycin [Susceptibility]

256

1428

1.56

10.23

3.0

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

304

2.26

10.21

4.8

5.1

—

(3035880) pH of Pleural fluid

264

1485

1.55

10.17

1.4

1.3

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

255

1424

1.56

10.14

1.8

—

(3028433) Virus identified in Specimen by Culture

158

781

1.76

10.08

1.2

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

528

3388

1.36

10.08

1.1

66.25

3726.86

iu/ml

0.58

678

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

390

2379

1.43

10.06

1.1

1.99

1.95

iu/ml

0.02

(43055442) Apixaban [Mass/volume] in Serum or Plasma

357

2.14

10.02

1.7

1.5

102.51

115.01

ug/l

0.56

295

(3000034) Microalbumin [Mass/volume] in Urine

379

2305

1.43

9.94

3.4

2.9

61.19

44.70

mg/l

0.48

274

1644

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

877

6047

1.27

9.91

1.3

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

180

928

1.69

9.90

1.5

1.6

3.66

6.74

nmol/l

0.60

149

784

(3034274) Bile acid [Moles/volume] in Serum --fasting

228

1251

1.59

9.80

1.6

7.64

11.37

umol/l

1.88

165

892

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

507

3249

1.36

9.78

1.6

1.5

60.20

58.93

0.29

343

2042

(3041672) Baker's yeast Ab [Presence] in Serum

3.88

9.72

1.1

1.0

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

529

3416

1.35

9.71

1.6

1.5

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

149

2.80

9.69

2.3

2.1

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

114

517

1.92

9.60

2.6

2.4

147.51

166.19

au/ml

0.12

(3035320) C reactive protein [Mass/volume] in Body fluid

296

1729

1.49

9.59

2.4

2.5

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

143

698

1.78

9.55

2.7

3.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

237

1321

1.56

9.54

1.5

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1649

16757

0.85

9.48

1.9

1.8

—

(3000012) Reticulocyte production index

583

3835

1.33

9.46

2.0

2.3

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

299

1758

1.48

9.39

1.4

1.31

1.32

promille

0.05

230

1342

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

285

1661

1.49

9.35

1.3

174.09

478.99

titre

1.92

138

(3029634) Reagin Ab [Titer] in Serum by VDRL

416

2602

1.39

9.34

2.2

2.1

2.93

6.45

titre

0.78

(3041096) Erythrocytes [Presence] in Urine by Automated

7596

61653

1.09

9.32

4.2

3.5

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

180

945

1.66

9.28

1.4

61.96

63.14

0.18

147

771

(3006245) CD3-CD19+ cells/100 cells in Blood

144

711

1.76

9.27

2.0

10.60

10.33

0.08

131

644

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

140

688

1.77

9.16

1.1

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

141

695

1.76

9.14

1.2

0.31

g/l

0.12

111

565

(3019832) Treponema pallidum Ab [Presence] in Serum

1293

9383

1.20

9.06

1.6

1.5

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

133

646

1.79

9.06

1.2

110.14

113.23

0.54

113

575

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

637

4275

1.30

8.97

1.9

1.7

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

666

4501

1.29

8.89

3.7

3.2

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

152

773

1.71

8.85

1.1

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

234

1325

1.54

8.82

1.1

1.87

6.86

nmol/l

2.63

258

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

143

716

1.74

8.80

1.1

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

257

2.27

8.79

2.1

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

143

717

1.73

8.76

2.0

1.9

29.59

29.94

0.10

134

670

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

527

3469

1.32

8.56

1.6

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

805

5598

1.25

8.53

1.3

562.64

576.42

mg/l

0.14

758

5331

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

293

1753

1.45

8.47

1.2

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

140

705

1.73

8.46

1.2

—

(1616796) Gas panel - Central venous blood

840

5877

1.25

8.44

4.2

3.6

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

290

2.16

8.42

1.4

1.5

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

719

4942

1.27

8.41

1.3

3.81

3.83

mmol/l

0.14

667

4653

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

463

2999

1.34

8.41

1.1

7.55

12.14

au/ml

—

147

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

775

5381

1.26

8.33

2.0

1.7

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

361

2.02

8.31

1.3

1.2

1043.40

138.77

ng/l

0.45

242

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

125

613

1.77

8.29

1.1

1.2

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

229

1310

1.52

8.27

1.1

28.60

25.78

u/l

0.31

207

1170

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

327

2.07

8.25

1.2

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

431

2771

1.35

8.23

1.1

—

(3024263) Appearance of Synovial fluid

235

1355

1.51

8.18

1.3

—

(40762365) Oxygen content in Arterial blood by calculation

441

1.91

8.18

4.0

2.8

14.40

14.83

ml/dl

0.72

411

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

226

1294

1.52

8.14

2.7

2.8

38.59

37.92

0.20

135

724

(4212803) Bone marrow aspirate examination

222

2.31

8.12

1.0

1.1

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

228

1309

1.52

8.11

1.1

91.81

85.73

u/l

0.56

207

1172

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

191

1055

1.57

8.08

1.9

2.0

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

175

948

1.61

8.04

1.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

268

2.17

7.99

2.0

2.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

628

4285

1.28

7.84

1.3

213.74

211.08

miu/ml

0.06

235

1756

(3028626) Oxygen [Partial pressure] in Capillary blood

812

5710

1.24

7.82

3.1

2.9

7.94

8.00

kpa

0.51

795

5581

(3016750) Collection duration of Urine

260

1546

1.46

7.81

2.5

2.1

491.83

500.18

min

0.82

203

1109

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

3329

26189

1.11

7.67

3.8

3.5

—

(3023410) Appearance of Cerebral spinal fluid

344

2164

1.38

7.57

1.6

1.5

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

224

1302

1.50

7.55

1.4

1.17

1.24

nmol/l

0.51

170

1001

(3042631) Mycobacterium sp identified in Specimen

555

3760

1.29

7.36

2.8

2.6

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

186

1045

1.55

7.35

1.9

2.0

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

186

1046

1.55

7.33

1.9

2.0

—

(3000060) B lymphocytes [#/volume] in Blood

101

485

1.81

7.25

1.9

2167.27

1013.26

e6/l

0.35

261

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

125

640

1.70

7.20

1.6

2.1

193.51

186.93

0.24

120

603

(3048879) Bone marrow aspiration report

147

786

1.63

7.17

1.6

1.7

—

(3020393) Adenovirus Ag [Presence] in Stool

202

2.28

7.14

1.2

1.1

—

(3008295) Osmolality of Serum or Plasma

376

2430

1.35

7.02

1.4

278.96

277.36

mosm/kgh2o

0.61

278

1884

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

314

1.99

6.92

1.2

1.3

288895.01

243854.72

nmol/l

0.07

260

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

102

499

1.78

6.91

1.0

1.1

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

375

1.90

6.87

1.3

1.2

—

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

147

2.48

6.83

1.1

1.4

114.19

1339.98

u/l

1.35

131

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

440

2922

1.31

6.82

1.1

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

679

4759

1.24

6.81

1.4

144.54

168.56

pmol/l

0.79

665

4637

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

306

1.99

6.70

2.4

2.6

72.35

74.52

pmol/l

0.06

266

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

350

2260

1.35

6.60

1.8

1178.67

2993.04

titre

1.08

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

261

1606

1.41

6.60

1.7

—

(3028717) Thiamine [Mass/volume] in Blood

217

2.16

6.45

1.1

—

(3022689) Creatine [Moles/volume] in Urine

130

695

1.63

6.40

1.4

1.5

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

254

1565

1.41

6.39

1.4

1.3

1.12

1.41

u/ml

0.33

163

877

(3009466) Valproate [Moles/volume] in Serum or Plasma

482

3270

1.28

6.39

4.8

354.00

360.42

umol/l

0.45

411

2783

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

140

763

1.60

6.38

1.5

1.4

15.98

15.59

pmol/l

0.18

124

624

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

132

2.50

6.30

1.3

14.72

19.07

pmol/l

0.83

112

(1175426) CD3 cells/100 lymphocytes in Blood

268

1672

1.39

6.29

2.0

71.22

71.96

0.32

254

1597

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

241

1478

1.42

6.24

1.2

1.1

48.98

45.42

mg/l

0.35

218

1223

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

223

1349

1.44

6.23

1.1

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

263

1639

1.40

6.22

2.0

16.19

16.31

0.06

253

1591

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

232

2.10

6.21

1.2

71.87

112.54

ug/l

1.68

146

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

3.05

6.21

1.0

1.2

181.11

180.97

ug/g

0.00

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

440

1.78

6.16

2.3

1.8

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

229

2.09

6.04

1.5

1.8

—

(21494815) CD4 cells/100 lymphocytes in Specimen

298

1906

1.36

6.03

2.0

2.1

38.85

37.46

0.74

285

1872

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

230

1409

1.42

6.01

1.1

324.00

301.25

mg/l

0.44

213

1223

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

138

762

1.57

5.98

1.3

341.38

242.20

ug/l

0.22

415

(3011436) Histone Ab [Units/volume] in Serum

490

1.72

5.95

1.0

1.1

—

26.80

u/ml

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

3683

29503

1.09

5.89

1.4

—

(3021901) Oxygen saturation in Capillary blood

691

4933

1.22

5.89

3.2

2.8

—

(4281824) Cell count and differential, peritoneal fluid

392

2619

1.30

5.89

1.2

1.1

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

330

2152

1.33

5.89

1.1

73.98

71.13

au/ml

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

159

910

1.52

5.88

1.6

1.4

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

143

2.37

5.80

1.5

1.1

52.25

42.87

mg/l

1.21

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

331

1.86

5.69

1.0

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

206

1251

1.43

5.68

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

111

590

1.64

5.65

1.1

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

190

2.15

5.59

1.2

1.3

1.18

1.03

ml/s/173m2

0.36

118

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

219

2.06

5.57

2.4

2.2

54.35

61.17

0.56

136

(21491868) Cryoglobulin [Mass/volume] in Serum

141

797

1.54

5.55

1.2

0.20

0.63

g/l

—

(3023436) Glucagon [Mass/volume] in Serum or Plasma

120

2.46

5.50

1.7

1.6

240.00

199.88

ng/l

0.49

106

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

268

1.95

5.48

1.2

1.1

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

418

1.75

5.47

1.1

—

(3002079) Sodium [Moles/time] in 24 hour Urine

174

1032

1.47

5.45

1.2

160.91

161.20

mmol/24h

0.01

174

1032

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

319

1.85

5.37

2.5

2.7

0.56

0.52

u/field

0.11

319

(3006576) Bicarbonate [Moles/volume] in Blood

160

938

1.48

5.32

6.4

6.3

24.82

25.16

mmol/l

0.45

146

848

(3010370) Gastrin [Moles/volume] in Serum or Plasma

352

1.80

5.29

1.6

1.8

52.93

56.44

pmol/l

0.10

292

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

124

690

1.56

5.26

1.2

1.3

3.09

3.37

umol/l

0.43

116

628

(3029075) Extractable nuclear Ab panel - Serum

116

636

1.59

5.24

1.1

1.0

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

681

4917

1.21

5.22

1.4

28.39

31.74

e6/l

0.15

527

3806

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

134

2.33

5.21

5.6

4.5

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

108

583

1.61

5.21

1.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

261

1.93

5.20

1.0

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

270

1745

1.35

5.18

1.7

1.6

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

681

4922

1.21

5.17

1.5

1.4

4773.02

1722.56

e6/l

0.46

549

4031

(3044290) Cell count panel - Cerebral spinal fluid

641

4610

1.21

5.13

1.4

1.3

—

(3016018) Differential panel - Cerebral spinal fluid

358

2413

1.29

5.10

1.4

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

526

1.64

5.09

1.2

1.1

—

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

170

2.15

5.01

2.3

19.41

15.78

0.23

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

295

1942

1.32

5.01

4.6

5.0

105.98

119.41

u/ml

0.09

581

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

187

1145

1.42

4.99

1.2

1.1

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

130

741

1.52

4.98

1.4

21.58

20.79

0.12

116

669

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

150

883

1.48

4.93

1.5

2.1

160.45

160.01

0.02

138

822

(3036071) Salmonella sp Ab [Titer] in Serum

108

592

1.59

4.91

1.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

194

1200

1.41

4.90

1.1

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

224

1424

1.37

4.81

1.8

1.9

2.76

2.50

u/field

0.16

155

997

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

528

1.61

4.80

1.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

413

2857

1.26

4.79

1.3

1.2

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

106

583

1.58

4.77

1.1

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

423

1.68

4.75

1.1

1.0

0.65

0.77

u/ml

0.17

208

(3017569) Oxygen content in Arterial blood

196

1222

1.39

4.74

2.4

2.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

426

2962

1.25

4.74

1.1

1.78

1.57

u/ml

0.14

207

1407

(3001893) Eosinophils/100 leukocytes in Pleural fluid

141

827

1.48

4.74

1.4

2.90

2.59

0.16

115

693

(3023511) Choriogonadotropin [Units/volume] in Urine

195

1216

1.39

4.71

1.3

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

158

949

1.45

4.70

1.6

2.2

158.27

266.01

ug/l

0.26

151

902

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

315

1.79

4.68

1.0

1.1

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

243

1572

1.34

4.68

2.1

2.0

—

(40761536) Microorganisms panel - Urine sediment

2149

20473

0.90

4.66

5.1

4.1

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

335

1.76

4.64

2.3

2.0

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

242

1.90

4.60

1.0

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

541

1.59

4.59

1.1

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

131

2.25

4.59

1.0

1.1

—

(3010503) CD19 cells [#/volume] in Blood

228

1466

1.35

4.58

2.5

0.16

0.39

e9/l

1.84

220

1420

(3024666) Lithium [Moles/volume] in Serum or Plasma

163

992

1.43

4.54

12.1

12.4

0.64

mmol/l

0.11

151

901

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

186

1159

1.40

4.53

1.2

1.3

—

(44786800) Granulocytes/100 leukocytes in Body fluid

344

1.74

4.53

1.3

19.68

25.34

0.92

264

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

315

2125

1.29

4.51

1.9

2.1

2.90

2.21

u/field

0.82

141

861

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

169

1037

1.42

4.50

1.2

1.1

1.19

1.09

u/l

0.25

497

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

198

1249

1.38

4.49

1.1

9.84

9.11

iu/ml

0.14

282

(40765096) Chromosome analysis panel by Banding

124

717

1.50

4.49

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

105

586

1.56

4.47

1.1

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

161

981

1.43

4.46

1.1

2.15

6.28

u/ml

3.81

148

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

195

1229

1.38

4.45

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

112

635

1.53

4.44

1.8

1.6

9.38

9.17

ug/l

0.21

112

635

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

177

1098

1.40

4.44

1.1

1.2

—

(40768800) Prostate Pathology biopsy report

775

5751

1.17

4.43

1.2

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

103

574

1.56

4.41

1.9

1.8

9.71

8.97

mg/l

0.71

462

(3033923) Metanephrine [Moles/time] in 24 hour Urine

513

1.59

4.40

1.1

0.75

0.79

umol/24h

0.10

247

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

285

1905

1.30

4.39

1.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

117

672

1.51

4.38

1.6

1.5

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

212

1359

1.36

4.36

1.9

1.8

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

110

625

1.53

4.33

1.5

1.6

0.40

0.39

ug/l

0.12

403

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

260

1.84

4.32

1.1

16.86

19.69

u/l

0.75

168

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

359

2478

1.26

4.30

1.6

1.5

25.71

29.37

1.27

236

1524

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

286

1922

1.29

4.25

1.5

1.4

0.31

0.29

nmol/l

0.14

211

1375

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

211

1359

1.35

4.23

1.9

1.8

—

(43055459) Dabigatran [Mass/volume] in Serum or Plasma

2.59

4.20

1.3

1.4

140.31

122.83

ug/l

0.13

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

197

1257

1.36

4.19

3.5

3.4

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.65

4.19

1.0

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

364

2525

1.25

4.19

1.1

0.67

1.05

u/ml

1.23

140

959

(3025130) Human papilloma virus identified in Specimen

318

2171

1.27

4.18

1.6

1.7

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

378

2636

1.25

4.16

1.1

3.30

3.70

u/ml

0.25

178

1192

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

104

2.34

4.14

1.1

1.2

—

(3005011) Chlamydia sp Ab [Titer] in Serum

271

1.80

4.10

1.9

1.6

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

106

607

1.52

4.06

1.3

109.59

138.28

nmol/l

1.38

433

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

172

1081

1.38

4.04

1.6

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

398

1.64

3.97

1.4

11.18

11.06

0.02

195

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

118

2.21

3.91

4.5

3.3

—

(3028707) Methadone [Presence] in Urine by Screen method

271

1833

1.29

3.87

1.9

2.6

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

348

1.67

3.86

1.3

1.2

44.67

41.33

mg/l

0.20

295

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

226

1.84

3.86

1.0

0.52

0.43

u/ml

0.06

147

(3002621) Streptococcal DNAse B [Units/volume] in Serum

190

1.92

3.81

1.1

1.0

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

228

1.83

3.76

1.1

1.2

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

562

1.52

3.76

1.1

—

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

185

1.92

3.75

1.2

24.33

23.31

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

173

1.96

3.75

1.3

1.2

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

372

1.63

3.71

3.0

2.4

87.75

68.35

mg/l

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

145

900

1.40

3.70

1.3

1.2

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

132

807

1.42

3.67

1.3

1.4

59.01

57.19

0.21

111

691

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

374

1.63

3.65

1.0

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

151

948

1.38

3.62

1.7

89.46

119.82

umol/l

1.18

485

(3026480) Teichoate Ab [Titer] in Serum

219

1.82

3.60

1.2

1.0

—

2.00

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

342

1.65

3.60

1.3

57.26

49.47

0.61

156

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

238

1.79

3.59

1.2

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

257

1746

1.28

3.58

1.2

1.3

2.03

2.21

mmol/l

1.89

236

1623

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

246

1.77

3.52

1.1

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

338

1.64

3.50

1.5

1.2

595.12

162.09

u/l

0.39

237

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

4.34

3.50

1.4

1.1

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

130

2.07

3.48

1.2

1.1

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

148

933

1.38

3.47

1.1

441.61

700.84

ng/l

0.44

229

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

160

1.95

3.46

4.8

4.6

—

(3044242) Glucose [Moles/volume] in Arterial blood

190

1246

1.33

3.46

2.3

1.9

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

504

1.52

3.43

1.2

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

2.54

3.37

1.3

1.2

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

107

641

1.45

3.36

10.4

7.9

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

277

1.69

3.31

1.0

0.73

1.74

u/ml

0.48

223

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

127

2.05

3.31

1.2

1.1

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

189

1248

1.32

3.30

1.6

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

546

5534

0.85

3.29

4.3

3.5

28.44

27.48

mg/l

0.22

335

3543

(3002619) Bacteria identified in Specimen by Culture

497

1.50

3.24

1.2

1.3

—

(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum

140

1.98

3.24

1.1

1.4

—

19393.00

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

428

1.54

3.22

1.7

2.2

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

554

1.47

3.22

10.7

7.7

—

(3008536) Aspergillus sp Ab [Presence] in Serum

498

1.50

3.21

1.8

2.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

172

1126

1.33

3.20

1.3

1.2

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

131

824

1.38

3.16

1.0

1.1

1599.17

1554.47

miu/ml

0.17

131

824

(3004451) EKG impression Narrative

198

1330

1.29

3.08

1.3

—

(3034426) Prothrombin time (PT)

112

690

1.41

3.06

1.3

1.2

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

264

1.68

3.06

1.1

—

(3009871) Measles virus Ab [Titer] in Serum

115

712

1.40

3.05

1.6

1.7

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

188

1.80

2.99

1.1

1.2

0.27

0.21

nmol/l

0.26

125

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

157

1.88

2.98

1.0

—

(3024869) Neuronal Ab [Presence] in Serum

479

1.49

2.97

1.1

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

144

930

1.35

2.97

2.3

55.09

52.49

umol/l

0.38

110

776

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

405

1.52

2.88

1.5

1.4

74.58

72.60

0.61

390

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

350

1.56

2.88

6.1

4.5

55.15

49.72

ug/min

0.32

284

(3009015) Lactate [Moles/volume] in Synovial fluid

283

1.63

2.85

1.3

6.12

6.53

mmol/l

0.14

138

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

135

1.93

2.84

1.1

41.55

104.37

u/l

0.66

101

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

2.37

2.81

1.1

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

218

1.71

2.80

1.0

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

142

1.90

2.80

1.3

1.1

13.57

15.16

nmol/l

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

168

1.81

2.74

1.1

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

2.23

2.73

1.0

1.1

—

(3017509) Phencyclidine [Presence] in Urine

131

1.92

2.73

1.5

1.4

—

(3025577) Chromium [Mass/volume] in Blood

243

1706

1.24

2.67

2.0

2.1

2.35

2.32

ug/l

0.05

198

1426

(40762887) Creatinine [Moles/volume] in Blood

2.50

2.63

1.2

—

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

401

1.49

2.60

1.6

1.5

2422.39

709.24

mu/l

0.58

386

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

210

1.70

2.60

1.0

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

2.46

2.54

2.9

3.4

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

470

1.44

2.48

1.7

1.6

71.78

88.31

au/ml

0.19

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

2.12

2.45

1.2

1.1

199.07

290.98

nmol/l

2.41

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

143

1.82

2.44

1.1

1.4

—

(3010421) pH of Blood

883

6919

1.11

2.40

5.1

3.9

7.42

1.04

785

6330

(3028679) Herpes simplex virus Ab [Presence] in Serum

138

919

1.30

2.38

1.2

1.1

—

(3000285) Sodium [Moles/volume] in Blood

332

1.52

2.38

1.1

1.2

—

(3052592) Norovirus Ag [Presence] in Stool

518

1.41

2.37

1.5

1.3

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

2.17

2.35

1.0

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

411

1.46

2.34

1.1

1.2

79.84

87.02

0.61

133

(3019977) pH of Arterial blood

213

1499

1.23

2.34

2.9

2.5

7.42

0.50

537

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

801

6254

1.11

2.34

1.7

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

624

1.36

2.30

1.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

181

1254

1.25

2.30

1.2

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

311

2277

1.19

2.29

1.5

—

(3020874) Milk IgE Ab [Units/volume] in Serum

135

902

1.30

2.29

1.1

1.0

1.33

1.14

u/ml

0.09

279

(3017937) Magnesium [Moles/time] in 24 hour Urine

2.33

2.28

1.3

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

200

1404

1.24

2.26

6.1

6.4

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

132

882

1.30

2.24

2.8

2.9

29.51

28.62

umol/l

0.45

672

(3026470) Cobalt [Mass/volume] in Blood

245

1760

1.21

2.23

2.0

4.69

3.59

ug/l

1.10

222

1615

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

3.47

2.22

1.0

1.1

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

395

1.45

2.21

1.4

1.2

0.31

1.60

mmol/l

4.43

249

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

1.98

2.20

1.0

0.10

0.06

u/ml

—

(40757373) Influenza virus identified in Isolate

504

1.40

2.20

1.8

1.5

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

269

1.55

2.19

1.0

1.1

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

111

1.88

2.16

1.8

1.5

3.28

0.89

mg/l

0.80

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

111

1.88

2.16

1.8

1.5

2.38

2.54

mg/l

0.06

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

111

1.88

2.16

1.8

1.5

1.43

2.78

mg/l

0.86

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

111

1.88

2.16

1.8

1.5

0.69

1.84

mg/l

1.61

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

111

1.88

2.16

1.8

1.5

4.55

3.40

mg/l

0.32

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

111

1.88

2.16

1.8

1.5

1.16

1.93

mg/l

0.34

(40765089) Chromosome analysis panel - Blood by G-banded

223

1.60

2.13

1.0

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

335

1.48

2.10

1.6

1.4

69.14

73.34

0.44

285

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

230

1653

1.21

2.10

1.2

1.1

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

240

1732

1.20

2.10

1.2

10.16

9.21

mmol/l

2.09

226

1635

(3050794) Legionella sp Ab [Presence] in Serum

218

1.59

2.07

1.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

431

1.41

2.04

1.2

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

101

1.89

2.04

1.0

0.26

0.12

u/ml

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

198

2087

0.82

2.02

1.4

1.5

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

425

1.41

2.01

2.6

2.7

848.02

1912.58

u/l

1.14

379

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

2.25

2.01

7.0

9.7

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

603

1.34

1.99

1.1

83.90

86.07

0.20

294

(43055514) Macroprolactin [Presence] in Serum or Plasma

297

1.49

1.99

1.7

1.5

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

121

1.79

1.98

1.3

1.2

0.05

0.07

g/l

0.99

(3027874) Urate [Moles/volume] in Urine

1.96

1.2

1.0

1.74

1.78

mmol/l

0.03

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

119

802

1.29

1.95

2.8

2.5

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

119

802

1.29

1.95

2.8

2.5

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

509

1.37

1.94

1.4

1.2

1.49

1.66

mmol/l

0.72

306

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

3.02

1.94

1.1

1.0

—

(3036180) Methadone [Presence] in Urine

570

1.34

1.91

1.7

1.8

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

149

1.69

1.89

1.2

1.6

0.72

0.75

umol/l

0.13

111

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

416

1.40

1.89

1.5

1.6

—

(3040151) Glucose [Moles/volume] in Capillary blood

395

3001

1.14

1.88

6.2

9.5

7.56

7.45

mmol/l

0.21

305

2481

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

117

1.78

1.87

1.8

1.5

2.20

1.94

mg/l

0.08

(3011288) Drugs identified in Urine by Screen method

348

2621

1.15

1.87

2.3

3.0

—

(40762814) Titanium [Mass/volume] in Blood

498

1.36

1.86

2.4

2.3

2.84

3.69

ug/l

2.02

172

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

112

1242

0.78

1.84

1.4

1.5

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

157

1.66

1.84

1.1

1.0

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

619

1.32

1.84

1.1

81.83

86.39

0.73

301

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

105

1.82

1.84

1.1

1.2

5530.71

2720.88

ng/l

0.25

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

411

1.39

1.84

1.2

72.59

75.01

0.16

126

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

2.32

1.84

1.2

1.0

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

346

1.43

1.83

1.2

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

198

1.58

1.83

2.1

1.7

—

(3042301) Urate [Moles/volume] in Synovial fluid

2.21

1.81

1.0

264.43

381.05

umol/l

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

103

1150

0.78

1.80

1.3

1.4

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1702

13903

1.07

1.80

1.3

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

244

1794

1.18

1.79

1.0

305.03

345.40

ng/l

0.88

175

1252

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

104

1155

0.78

1.75

1.3

1.4

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

133

1.70

1.74

6.6

7.3

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

133

1.70

1.74

1.5

1.2

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

104

1154

0.78

1.74

1.3

1.4

—

(3027315) Oxygen [Partial pressure] in Blood

767

6083

1.10

1.74

5.3

4.0

8.34

8.52

kpa

1.85

746

5940

(3027035) Albumin [Mass/time] in 24 hour Urine

222

1.53

1.72

1.6

1.2

901.67

200.76

mg/24h

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

244

1802

1.18

1.72

1.0

738.97

732.46

ng/l

0.07

172

1210

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

104

1151

0.78

1.71

1.3

1.4

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

244

1804

1.18

1.70

1.0

43.99

42.85

ng/l

0.13

172

1240

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

440

1.36

1.69

1.0

1.1

1.63

3.54

pmol/l

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

2.55

1.68

2.4

5.3

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

103

698

1.28

1.66

2.0

2.1

44.98

40.35

u/l

0.09

634

(3014599) Egg white IgE Ab [Units/volume] in Serum

127

883

1.25

1.66

1.0

1.68

0.66

u/ml

0.47

191

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

346

1.41

1.66

1.1

1.2

—

(46235168) Fasting glucose [Moles/volume] in Blood

264

0.56

1.62

1.9

2.3

6.86

7.47

mmol/l

—

130

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

2.57

1.62

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

2.57

1.62

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

2.57

1.62

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

2.57

1.62

2.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

2.57

1.62

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

2.57

1.62

1.0

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

177

1.57

1.61

1.0

1.1

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

131

1.66

1.56

1.2

1.1

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

492

1.32

1.56

1.2

102.39

23.62

mg/l

0.53

360

(3030313) Adrenal Ab [Titer] in Serum

125

1.67

1.54

1.0

1.1

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

112

1.71

1.53

1.0

1.4

0.87

1.16

u/field

1.09

(3043238) Trisomy 21 risk [Likelihood] in Fetus

996

0.78

1.52

1.4

1.5

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

119

1.68

1.51

1.3

1.2

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

116

809

1.25

1.51

1.3

1.4

1522160.00

2016382.13

iu/ml

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

398

3079

1.12

1.50

1.7

2.1

—

(3019174) dRVVT (LA screen)

167

1.56

1.49

1.0

1.2

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

174

1.55

1.49

1.0

1.1

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

2.17

1.48

1.0

—

(3001019) Free T4 and TSH panel - Serum or Plasma

939

8765

0.93

1.48

1.7

—

(3008402) Methanol [Moles/volume] in Serum or Plasma

238

1.46

1.47

1.2

—

1.00

mmol/l

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

120

1.66

1.47

1.8

1.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

962

0.78

1.47

1.4

—

(3035510) Gentamicin [Mass/volume] in Serum or Plasma

1.85

1.45

5.8

6.0

0.76

1.19

mg/l

1.72

(3024316) Viscosity of Plasma

121

1.65

1.43

2.6

1.8

1.64

1.78

mpas

0.53

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

453

0.69

1.43

1.1

1.2

—

(3005033) Fetal Nuchal fold Thickness US

958

0.79

1.43

1.3

1.4

—

(3014891) Appearance of Pleural fluid

379

1.35

1.43

1.3

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

269

1.42

1.2

1.1

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

2.30

1.41

1.3

1.2

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

115

1.66

1.41

2.0

2.3

1.60

2.21

mg/l

1.31

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

208

0.54

1.41

1.4

1.2

—

(3013290) Carbon dioxide [Partial pressure] in Blood

755

6053

1.08

1.41

5.3

4.0

5.03

5.00

kpa

0.56

734

5911

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

283

0.61

1.38

1.4

1.5

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

2.23

1.38

2.6

2.2

1.68

1.76

mu/l

—

(3012501) Base excess in Blood by calculation

754

6052

1.08

1.37

5.3

4.0

2.75

2.58

mmol/l

0.86

532

4202

(40768793) Breast Pathology biopsy report

640

5104

1.09

1.36

1.3

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

665

1.25

1.36

1.5

1.3

36.39

37.26

0.07

449

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

2.60

1.34

1.0

1.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

215

1.45

1.33

1.1

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

445

1.31

1.32

1.4

219.91

163.41

titre

0.11

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

2.89

1.31

1.2

1.0

21.40

21.67

umol/l

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

223

1.44

1.31

1.2

1.1

12.86

18.77

iu/ml

0.43

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

446

1.30

6.7

6.9

—

(40767503) Oxygen content in Capillary blood by calculation

711

5711

1.08

1.29

2.9

2.6

15.64

16.27

3.83

418

2940

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

1.68

1.29

1.3

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

181

1.49

1.28

1.1

9.19

10.54

u/l

0.18

181

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

112

1.63

1.27

1.3

1.6

0.36

0.16

u/l

0.36

(3006567) Chloride [Moles/time] in 24 hour Urine

2.06

1.26

1.2

1.1

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

626

1.25

1.1

109.11

105.94

0.27

569

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

383

1.32

1.21

2.5

3.1

48.00

125.99

ng/l

2.64

126

(3016879) Cocaine [Presence] in Urine

472

3742

1.10

1.18

1.7

2.0

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

184

0.57

1.16

1.0

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

304

1.34

1.14

1.9

2.0

15.76

17.57

umol/l

0.76

304

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

201

1.43

1.13

2.0

2.2

0.54

0.89

mmol/l

1.09

125

(3032868) Hemoglobin electrophoresis panel in Blood

158

1.48

1.13

1.8

1.5

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

160

1193

1.16

1.11

1.1

1.05

1.08

ratio

1.83

423

(3012920) Ethanol [Mass/volume] in Serum or Plasma

1.98

1.10

1.1

1.3

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

117

1.56

1.09

1.1

8.66

8.56

mmol/l

0.11

117

(3044009) aPTT.lupus sensitive (LA screen)

167

1.46

1.08

1.0

1.2

—

(3020618) Glucose [Moles/volume] in Synovial fluid

1.61

1.07

1.0

1.1

5.65

5.33

mmol/l

0.17

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

446

1.27

1.05

1.2

1.8

1.67

2.45

ug/l

2.16

264

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

1.65

1.05

1.2

1.3

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

682

1.21

1.03

1.1

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

363

2869

1.10

1.02

1.7

1.6

—

(3012989) Citrate [Moles/time] in 24 hour Urine

1.91

1.01

1.1

1.5

2.37

2.10

mmol/24h

—

(3015183) Erythrocyte sedimentation rate

125

923

1.18

1.01

1.3

1.2

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

960

0.83

1.00

1.3

1.4

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

139

1037

1.16

0.99

17.8

16.1

1263.54

3860.63

nmol/l

0.86

132

992

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

156

1.45

0.99

1.1

1.0

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

121

1.51

0.97

1.9

1.4

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

179

1.41

0.96

1.1

1.0

—

(3033942) Copper [Moles/time] in 24 hour Urine

1.66

0.95

1.1

0.21

0.79

umol/24h

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

296

2327

1.11

0.94

1.1

1.10

1.15

u/ml

0.06

151

1075

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

650

1.20

0.94

1.8

1.6

—

47143335.86

iu/ml

—

(3019298) Eosinophils/100 leukocytes in Peritoneal fluid

1.74

0.94

2.3

1.2

0.54

0.56

0.02

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

180

1.40

0.93

1.5

27.86

42.60

1.18

115

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

248

1.33

0.91

1.1

2.08

1.73

umol/24h

1.64

248

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

206

1597

1.12

0.87

1.4

1.3

163.79

171.14

pmol/l

0.34

206

1597

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

337

2681

1.09

0.86

1.2

7.49

7.59

mmol/l

0.23

277

2322

(3022475) Manganese [Moles/volume] in Blood

132

1.45

0.86

1.3

—

(3018291) Platelet Ab [Presence] in Serum

1.83

0.86

1.1

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

166

1273

1.13

0.84

1.5

4.48

3.89

0.22

270

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

104

1.50

0.84

11.8

8.6

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

1.57

0.83

31.9

11.8

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

1.93

0.83

1.0

—

(3028300) Cannabinoids [Presence] in Urine

499

4042

1.07

0.83

1.7

2.0

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.71

0.82

1.0

1.1

—

(3000764) Benzodiazepines [Presence] in Urine

495

4010

1.07

0.82

1.7

2.0

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

121

1208

0.87

0.81

1.1

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

582

1.19

0.81

1.2

1.3

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

1.61

0.80

1.2

1.4

214.98

524.38

nmol/l

3.93

(3027008) Opiates [Presence] in Urine

497

4031

1.07

0.80

1.7

1.9

—

(3009992) Blasts/100 cells in Bone marrow

0.00

0.79

0.0

1.5

—

17.59

—

(36304315) Certolizumab Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.79

0.0

1.2

—

468.00

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

113

1.46

0.78

1.0

0.05

0.51

u/ml

0.83

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

184

0.66

0.78

1.0

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

0.00

0.78

0.0

2.3

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

271

1.28

0.77

1.1

—

(3027944) Amphetamines [Presence] in Urine

486

3949

1.07

0.76

1.7

1.9

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

326

1.25

0.76

1.4

1.6

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

235

1853

1.10

0.76

1.2

—

(3018001) Oat IgE Ab [Units/volume] in Serum

100

1.48

0.74

1.1

1.0

0.57

0.26

u/ml

—

(3016228) CD19 cells/100 cells in Blood

128

976

1.14

0.74

2.1

2.0

8.38

8.25

0.04

123

949

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

1.63

0.73

1.1

1.3

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

129

986

1.14

0.72

13.7

11.5

747.04

1860.71

nmol/l

0.56

122

944

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

198

1.32

0.71

1.1

1.0

0.36

0.53

u/ml

0.14

144

(3007919) Fasciola sp Ab [Titer] in Serum

1.74

0.70

1.0

1.1

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

763

6304

1.05

0.70

1.4

1.3

31.63

34.47

iu/l

1.45

644

5440

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

616

1.17

0.70

1.8

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

691

6315

0.95

0.70

1.4

1.3

—

(3011325) HIV 1+2 Ab [Presence] in Serum

102

0.60

0.68

1.0

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

192

1.31

0.68

1.1

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

231

1.28

0.67

3.2

2.5

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

1.81

0.66

1.8

1.1

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

109

830

1.14

0.66

1.5

1.6

8.17

5.03

ug/l

0.25

578

(3035082) Kappa light chains [Mass/volume] in Urine

1.55

0.66

1.1

0.04

0.19

g/l

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

173

1355

1.11

0.66

3.9

3.7

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

286

1.24

0.65

1.1

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

118

1.40

0.65

2.1

3.8

—

0.00

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

1.60

0.65

1.0

1.1

1714.29

2323.42

titre

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

194

1.30

0.64

1.2

1.1

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

493

1.18

0.64

1.3

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

185

0.70

0.64

2.7

3.0

—

(3035060) Mercury [Moles/volume] in Blood

1.74

0.64

1.2

2.0

7.00

18.35

nmol/l

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

1.74

0.64

1.0

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

327

1.22

0.63

2.4

1.6

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

218

1.27

0.62

1.0

1.1

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

184

0.71

0.62

5.5

6.0

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

486

3985

1.06

0.62

3.1

3.6

34.27

39.91

u/ml

0.27

474

3858

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

1.67

0.61

1.0

—

(3015350) Toxocara sp Ab [Presence] in Serum

1.67

0.61

1.0

—

(3030940) RBC casts [#/area] in Urine by Computer assisted method

0.00

0.61

0.0

1.1

—

(3028917) Waxy casts [#/area] in Urine by Computer assisted method

0.00

0.61

0.0

1.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

440

1.18

0.60

1.4

1.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

920

0.88

0.60

1.8

1.7

—

(21494814) CD8 cells/100 lymphocytes in Specimen

123

952

1.12

0.60

2.0

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

724

0.86

0.59

1.3

1.5

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

228

1.26

0.59

6.0

5.4

—

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

136

1.34

0.58

1.5

1.4

0.93

1.80

0.44

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

1.45

0.58

1.0

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.61

0.58

1.0

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

1.51

0.58

1.1

1.2

—

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

159

1.31

0.58

1.5

20.11

12.20

0.55

108

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

114

1.37

0.57

1.1

1.0

—

(3007456) Orange IgE Ab [Units/volume] in Serum

1.68

0.57

1.0

0.08

0.05

u/ml

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

183

1.28

0.56

1.3

1.5

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

137

1073

1.11

0.56

1.2

1.3

66.17

57.89

0.36

121

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

438

1.17

0.54

2.3

3.1

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

1.47

0.53

1.4

1.5

—

(3013762) Body weight Measured

1.49

0.53

1.0

1.2

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

186

1.26

0.51

2.5

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

117

1.34

0.50

1.2

1.1

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

140

1.30

0.50

1.2

1.1

—

(3046861) Legionella sp Ag [Presence] in Urine

155

0.73

0.48

1.0

1.1

—

(3025549) Creatine [Moles/time] in 24 hour Urine

219

1.23

0.48

1.5

1.4

—

14.17

—

(4034850) Laboratory test

967

8120

1.03

0.48

13.9

10.3

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

162

1523

0.92

0.45

1.5

—

(3051671) S100 calcium binding protein B [Mass/volume] in Serum

1.41

0.45

1.8

2.4

0.09

0.10

ug/l

0.22

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

1.38

0.44

1.0

1.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

232

1887

1.07

0.44

1.1

4.16

3.18

u/ml

0.32

706

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

262

1.19

0.43

1.1

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

175

1.24

0.43

2.6

2.8

7.82

58.46

pmol/l

1.37

(1617658) Protocol used for examination of sentinel lymph nodes

199

1849

0.93

0.42

1.0

—

(3003843) Paprika IgE Ab [Units/volume] in Serum

1.55

0.42

1.0

0.40

0.05

u/ml

—

(36304079) Mucus [Presence] in Urine sediment

0.00

0.41

0.0

1.1

—

(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid

1.36

0.41

1.4

1.1

0.07

0.05

mg/l

0.45

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

162

1515

0.93

0.41

1.5

—

(40760866) Procollagen type III.N-terminal propeptide [Units/volume] in Serum

0.00

0.41

0.0

1.1

—

(3041184) Isoniazid [Presence] in Urine

1.50

0.41

1.6

2.9

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

1.31

0.39

1.1

1.2

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

1.35

0.38

1.1

1.0

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

1.30

0.37

1.1

1.0

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

163

1.22

0.37

1.0

1.2

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

209

1708

1.06

0.37

1.5

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

211

1.19

0.36

1.1

1.2

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

124

1.26

0.36

1.1

1.0

—

(3028271) Lactate [Moles/volume] in Capillary blood

510

4266

1.04

0.36

2.0

1.9

1.74

1.73

mmol/l

0.09

500

4161

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

440

1.12

0.35

1.1

1.0

4.84

9.29

u/ml

1.42

232

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

125

1.25

0.34

1.2

1.1

—

(3042517) Benzodiazepines panel - Urine

133

1.24

0.34

1.3

2.7

—

(3002719) Hemoglobin [Mass/volume] in Urine

1.30

0.33

1.0

1.1

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

459

1.12

0.33

1.1

1.0

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

271

1.15

0.32

1.1

1.0

100.87

84.39

ug/l

0.83

206

(40758292) HTLV I+II Ab panel - Serum

376

0.88

0.31

1.4

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

138

1126

1.06

0.28

1.2

1.1

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

673

1.08

0.28

1.2

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

616

0.92

0.27

1.2

1.1

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.25

0.26

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

318

1.12

0.26

1.4

1.2

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

1.26

0.26

1.0

—

(3003740) Influenza virus B Ag [Presence] in Specimen

308

2578

1.04

0.25

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

319

1.12

0.25

1.4

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

319

1.12

0.25

1.4

1.2

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

1.18

0.24

1.1

1.0

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

143

1176

1.06

0.24

5.2

5.1

65.76

4223.91

u/ml

0.70

198

(40758358) Immune stain study

115

1.21

0.24

1.0

—

(3010937) Rubella virus Ab [Presence] in Serum

0.71

0.24

1.0

1.1

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

772

1.07

0.24

1.0

0.42

0.69

u/ml

0.28

189

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

1.36

0.23

1.2

—

(3035611) Eosinophils/100 leukocytes in Synovial fluid

189

1.15

0.23

1.3

1.8

0.57

0.81

0.45

149

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

108

1.21

0.23

1.0

0.05

0.64

u/ml

—

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

0.77

0.22

1.1

1.0

0.19

0.38

u/ml

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

672

0.93

0.22

1.1

—

(3017501) Neutrophils [#/volume] in Blood by Manual count

0.00

0.21

0.0

1.9

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

0.00

0.21

0.0

1.3

—

(3014178) Parietal cell Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(3051101) Glucose [Moles/volume] in Cord blood

490

1.08

0.21

4.6

6.0

—

(3039443) Prostate specific Ag panel - Serum or Plasma

507

4509

0.98

0.21

1.7

—

(3035153) Lemon IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(3006498) Trichoderma viride IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.2

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

112

1026

0.95

0.21

1.4

1.5

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.23

0.21

1.1

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

112

921

1.06

0.20

1.1

25.50

11.26

u/ml

—

(3044590) Delta aminolevulinate [Moles/volume] in Urine

0.00

0.20

0.0

1.0

—

14.25

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

318

0.90

0.20

1.2

84.34

65.12

u/ml

0.68

307

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

534

0.93

0.20

1.3

—

(3021855) Mononuclear cells [#/volume] in Cerebral spinal fluid

1.24

0.20

1.0

1.4

20.50

44.24

e6/l

—

(3002523) Influenza virus A Ag [Presence] in Specimen

306

2576

1.03

0.20

1.1

—

(3008607) Semen analysis panel

1.21

0.20

1.2

1.3

—

(3001729) Color of Synovial fluid

225

1.12

0.19

1.3

1.7

—

(3034614) HLA Ag [Interpretation]

1.18

0.19

1.3

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

241

2023

1.03

0.19

1.1

2.34

3.24

u/ml

0.59

101

893

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

553

1.07

0.18

2.5

2.4

7.85

7.39

mmol/l

0.39

333

(3011335) Digoxin [Mass/volume] in Serum or Plasma

243

0.89

0.18

2.1

2.3

—

(40763590) HLA-DQ beta [Type]

1.21

0.17

1.0

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

106

877

1.05

0.17

1.1

98.65

98.05

0.07

687

(3050129) First trimester maternal screen panel - Serum or Plasma

155

1397

0.96

0.16

1.5

1.4

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

384

0.93

0.15

1.1

1.2

—

(46236302) HLA-C [Type] by High resolution typing

1.19

0.15

1.0

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

1.19

0.15

1.0

—

(40760410) HLA-B [Type] by High resolution

1.19

0.15

1.0

—

(40760409) HLA-A [Type] by High resolution

1.19

0.15

1.0

—

(40768795) Lymph node Pathology biopsy report

296

2506

1.03

0.15

1.2

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

180

1.11

0.14

1.1

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

130

0.87

0.14

1.5

1.6

21.97

24.05

mmol/l

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

129

0.87

0.13

1.3

1.4

325.15

345.02

umol/24h

0.12

129

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

165

0.89

0.12

1.0

—

(3013293) Extractable nuclear Ab [Presence] in Serum

362

0.94

0.12

1.4

1.6

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

810

1.04

0.12

2.0

1.9

—

(3013862) HLA-DP [Type]

1.16

0.12

1.0

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

284

1.07

0.11

1.1

1.0

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

301

1.07

0.11

6.1

7.6

0.32

0.41

umol/l

0.47

271

(3012565) Volume of 24 hour Urine

155

1309

1.03

0.11

2.3

2.2

1910.21

1935.40

0.10

146

1139

(3003577) Lead [Moles/volume] in Blood

150

1.10

0.10

1.1

1.3

0.12

0.17

umol/l

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

660

1.04

0.10

2.8

2.4

147.75

150.81

nmol/l

0.06

566

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

823

7072

1.01

0.10

1.7

4.24

3.88

mg/l

0.33

661

5250

(36303858) Crystals [Presence] in Urine

1.14

0.10

1.6

1.1

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

126

1.10

0.09

1.0

0.01

0.14

u/ml

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

1.04

0.08

1.0

1.1

4.17

2.26

—

(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid

1.02

0.08

1.0

—

12217.43

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

1.02

0.08

2.0

2.2

—

(3017950) Salicylates [Moles/volume] in Serum or Plasma

0.82

0.08

1.0

1.3

—

1599.63

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.89

0.08

1.0

1.3

1.30

1.37

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

716

1.03

0.08

1.2

15.44

25.84

0.79

111

(3009677) Dengue virus Ab [Presence] in Serum

1.09

0.07

1.1

1.2

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.07

0.07

1.0

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

1.04

0.07

1.3

1.1

—

mmol/l

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

2459

21432

1.00

0.07

4.7

3.9

1.23

mmol/l

1.26

2217

18620

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

170

1.07

0.07

1.1

2.2

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

617

0.97

0.06

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

617

0.97

0.06

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

617

0.97

0.06

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

617

0.97

0.06

1.1

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

247

2115

1.01

0.06

1.5

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

155

1322

1.02

0.06

1.3

1.54

1.56

g/l

0.42

155

1322

(40763480) Human metapneumovirus Ag [Presence] in Specimen

120

1.09

0.06

1.4

1.3

—

(3020650) Glucose [Presence] in Urine

563

0.97

0.06

1.4

—

(3035933) Granulocytes/100 leukocytes in Blood

492

0.97

0.05

1.2

1.7

—

(3041806) Other cells [#/volume] in Blood by Manual count

174

0.95

0.04

1.7

1.5

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

328

1.03

0.04

1.8

3.3

35.35

40.62

umol/l

0.74

273

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

466

1.02

0.04

1.1

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

268

1.04

0.03

7.4

8.9

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

102

0.94

0.02

1.0

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

102

0.94

0.02

1.5

1.4

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

198

0.96

0.02

1.2

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

489

1.01

0.00

1.1

1.2

—

(3022806) Fractional oxyhemoglobin in Capillary blood

397

3439

1.00

0.00

2.0

1.8

88.86

89.42

0.97

392

3388

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

622

0.99

0.00

1.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

189

1635

1.00

0.00

1.0

0.23

0.43

u/ml

0.52

441

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

118

1.03

0.00

1.0

0.03

u/ml

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

123

0.99

0.00

1.0

0.03

0.14

u/ml

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

282

1.02

0.00

2.6

3.1

1.09

1.21

mg/l

0.34

209

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

494

1.00

0.00

1.3

1.2

—

(3029396) Erythrocyte agglutination [Presence] in Blood

186

0.98

0.00

2.1

2.4

—

(3004541) Aldosterone [Moles/volume] in Urine

0.00

0.0

1.2

—

(3039621) Maximum lysis.intrinsic coagulation system activated.heparin insensitive [Length fraction] in Blood by Rotational TEG

0.00

0.0

3.0

—

3.67

—

(3022670) pH of Venous cord blood

0.00

0.0

1.0

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.93

-0.00

1.0

—

(3035411) Chaetomium globosum IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.1

—

(3008896) Cortisol [Moles/volume] in Urine

0.00

-0.00

0.0

1.0

—

(3013851) Stachybotrys chartarum IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.1

—

(42529039) t(15;17)(q24.1;q21.1)(PML,RARA) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

4.0

—

(3006392) Corynebacterium diphtheriae [Presence] in Specimen by Organism specific culture

0.00

-0.00

0.0

1.0

—

(3026868) Penicillium brevicompactum IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.3

—

(3029889) Paecilomyces variottii IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.3

—

(3014257) Rhodotorula spp IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.3

—

Mortality – FinRegistry

↥

Association

Association between endpoint CD2_BENIGN_COLORECANI and mortality.

Females

Parameter	HR [95% CI]	p-value
CD2_BENIGN_COLORECANI	1.236 [1.14, 1.34]	< 0.001
Birth year	0.995 [0.99, 1.0]	0.223

During the follow-up period (1.1.1998 — 31.12.2019), 14200 out of 66651 females with CD2_BENIGN_COLORECANI died.

Males

Parameter	HR [95% CI]	p-value
CD2_BENIGN_COLORECANI	1.328 [1.21, 1.45]	< 0.001
Birth year	0.988 [0.98, 1.0]	0.006

During the follow-up period (1.1.1998 — 31.12.2019), 19311 out of 66453 males with CD2_BENIGN_COLORECANI died.

Mortality risk

Mortality risk for people of age

years, who have CD2_BENIGN_COLORECANI.

N-year risk	Females	Males
1	0.104%	0.227%
5	0.658%	1.578%
10	1.776%	3.844%
15	3.638%	7.17%
20	6.368%	12.114%

Relationships between endpoints

↥

Index endpoint: CD2_BENIGN_COLORECANI – Benign neoplasm of colon, rectum, anus and anal canal

GWS hits: 37

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Benign neoplasm of colon, rectum, anus and anal canal

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints